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APC antigen presenting cell
APS ammonium persulfate
BSA bovine serum albumin
BSL biosafety level
CD cluster of differentiation
CPE cytopathic effect
Cy5.5 (a cyanine dye with absorbance maximum at 675 nm and
emission maximum at 694 nm)
DC dendritic cell




ELISA enzyme-linked immunosorbent assay
ER endoplasmic reticulum
ERK extracellular signal-regulated kinases
FACS fluorescence associated cell sorter
FCS fetal calf serum
FFU focus forming unit
FITC fluorescein isothiocyanate
GM-CSF granulocyte-macrophage colony-stimulating factor
HCPS hantavirus cardiopulmonary syndrome
HEPES N-2-hydroxyethylpiperazine-N'-2-ethane-sulfonic acid
HFRS hemorrhagic fever with renal syndrome
HLA human leukocyte antigen
HRP horseradish peroxidase
HUVEC human umbilical vein endothelial cells
ICAM-1 intercellular adhesion molecule-1
IFN interferon
IL interleukin
IRDye800 (an infrared dye with absorbance maximum at 778 nm and
emission maximum at 806 nm)
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IRF interferon regulatory factors
ISRE interferon stimulated response element
kDa kiloDalton
KHF Korean hemorrhagic fever
LPS lipopolysaccharide
MAP kinase mitogen-associated protein kinase
MFI mean fluorescence intensity






PAMP pathogen-associated molecular patterns
PBS phosphate-buffered saline
PDGF platelet derived growth factor
PFA paraformaldehyde
PMBC peripheral blood mononuclear cells
PKR protein kinase R
poly I:C polyinosinic-polycytidylic acid
RNA ribonucleic acid
rpm revolutions per minute
RPMI 1640 Roswell Park Memorial Institute medium (for cell culture)
RT-PCR reverse transcriptase-polymerase chain reaction
SDS-PAGE sodium dodecyl sulphate-polyacrylamide gel electrophoresis
STAT signal transducer of activation and transcription
TAP transporter associated with antigen
TGF transforming growth factor
TNFα tumor necrosis factor α
Tris-HCl Tris-(hydroxymethyl)-aminomethan
TUNEL terminal-desoxynucleotidyl-transferase-mediated dUTP nick
end labeling
UV ultraviolet
VCAM-1 vascular cell adhesion molecule-1







PHV Prospekt Hill virus
SNV Sin Nombre virus
EBV Epstein Barr virus
CMV Cytomegalovirus
ECMV encephalomyocarditis virus
LCMV lymphocytic choriomeningitis virus
10
Summary
Hantaviruses represent important human pathogens and can induce
hemorrhagic fever with renal syndrome (HFRS) and hantavirus cardiopulmonary
syndrome (HCPS). Both diseases are characterised by endothelial dysfunction.
Although hantaviruses replicate in human endothelial cells they do not cause any
apparent cytopathic effect. This major paradox suggests that immunopathological
mechanisms might be involved in pathogenesis.
Activation of the endothelium might play a major role in the pathophysiology of
inflammatory processes eventually leading to endothelial dysfunction. Therefore, the
complex series of cellular events which occurs during inflammation was investigated
in hantavirus-infected human umbilical vein endothelial cells (HUVEC). The capacity
of pathogenic and rather nonpathogenic hantaviruses to induce an antiviral response
in HUVEC was compared. To develop a concept of hantavirus immunopathogenesis,
the role of immune cells in the course of an infection was evaluated.
However, the potential risk of accidental infection by hantaviruses in the
research laboratory necessitates special precautionary measures. Certain safety
prerequisites, including appropriate virus inactivation procedures to permit necessary
further processing of specimens outside of the biosafety level 3 laboratory, had to be
achieved prior to taking up the experimental part of this study. Virus inactivation and
depletion methods described in this study were shown to be suitable to prepare non-
infectious samples for further use in immunological, virological and cell biological
assays. With this knowledge and the appropriate safety precautions the systematic
experiments aimed at discovering pathogenic mechanisms of hantavirus disease
could be launched.
Infection of endothelial cells with both Hantaan virus (HTNV) or Tula virus
(TULV) did not induce activation of the highly conserved cytosolic serine/threonine
protein kinases p38 or p42/44. Moreover, it did not lead to activation of central
transcription factor NFκB. Likewise, a modulation of its inhibitor IκB-α could not be
observed after infection. Finally, the results did not reveal significantly increased
expression levels of cell adhesion molecules VCAM-1 or ICAM-1 in response to an
infection with HTNV or TULV. Thus, both hantaviruses presumably do not belong to
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the stress factors known to activate signalling events involved in inflammatory
responses.
The innate immune response triggered by HTNV and TULV was compared in
endothelial cells. Both HTNV- and TULV-infected cells showed increased levels of
molecules involved in antigen presentation. However, TULV-infected HUVEC more
rapidly upregulated HLA class I molecules. Interestingly, HTNV clearly induced the
production of interferon-β (IFN-β) whereas expression of this cytokine was barely
detectable in the supernatant or in extracts from TULV-infected HUVEC.
Nevertheless, the upregulation of HLA class I on both TULV- and HTNV-infected
cells could be blocked by neutralising anti-IFN-β antibodies. Most strikingly, the
antiviral MxA protein, which interferes with hantavirus replication, was induced
already 16 h after infection with TULV. In contrast, HTNV-infected HUVEC showed
no expression of MxA until 48 h postinfection. In accordance with the kinetic of MxA
expression TULV only inefficiently replicated in HUVEC whereas HTNV-infected cells
produced high titers of virus particles that decreased after 48 h postinfection. Both
hantavirus species, however, could replicate equally well in Vero E6 cells which lack
an IFN-induced MxA response. Taken together, the results obtained suggest that a
delayed induction of antiviral MxA in endothelial cells after infection with HTNV could




Hantaviren stellen wichtige menschliche Krankheitserreger dar und können das
Hämorrhagische Fieber mit renalem Syndrom (HFRS) sowie das Hantavirus
kardiopulmonale Syndrom (HCPS) hervorrufen. Beide Erkrankungen sind durch
endotheliale Funktionsstörungen charakterisiert. Obwohl sich Hantaviren in humanen
Endothelzellen replizieren, verursachen sie dabei keine offensichtlichen
zytopathischen Effekte. Dieses Paradoxon führt zu der Annahme, dass
immunpathologische Mechanismen eine bedeutende Rolle in der Pathogenese
dieser Erkrankung spielen könnten.
Die Aktivierung des Endothels, die schließlich zu endothelialen
Funktionsstörungen führt, ist für die Pathophysiologie entzündlicher Prozesse von
entscheidender Bedeutung. Folglich wurden die komplexen zellulären Ereignisse, die
im Verlauf einer Entzündung auftreten, in Hantavirus-infizierten humanen
Nabelschnur-Endothelzellen (HUVEC) untersucht. Die Fähigkeit pathogener
Hantaviren, eine antivirale Antwort in infizierten Endothelzellen auszulösen, wurde
mit der weniger pathogener Hantaviren verglichen. Mit dem Ziel, ein Konzept zur
Immunpathogenese bei einer Hantavirusinfektion zu entwickeln, wurde zudem die
Rolle von Immunzellen im Verlauf einer solchen Infektion untersucht.
Das Risiko, sich während der Arbeit im Forschungslabor versehentlich mit
Hantaviren zu infizieren, macht spezielle Sicherheitsmaßnahmen zwingend
erforderlich. Solche Richtlinien zum sicheren Umgang mit dem Virus selber mussten
erarbeitet werden, bevor mit dem experimentellen Teil der Arbeit begonnen werden
konnte. Erst dann war nämlich eine weitere Bearbeitung der Proben auch ausserhalb
des Hochsicherheitslabors möglich. Die hier beschriebenen Maßnahmen zur
Desinfizierung von infizierten Zellen und deren Zellkulturüberständen sind geeignet,
eine sichere Handhabung von Proben in immunologischen, virologischen sowie
zellbiologischen Untersuchungen zu gewährleisten. Mit dieser Gewissheit und unter
Einhaltung der Vorsichtsmaßnahmen konnte schließlich mit den Untersuchungen zu
den pathogenen Mechanismen der durch Hantaviren hervorgerufenen Erkrankungen
begonnen werden.
Eine Aktivierung der hochkonservierten zytosolischen Serin/Threonin
Proteinkinasen p38 und p42/44 konnte nach einer Infektion mit dem pathogenen
Hantaan Virus (HTNV) oder dem weniger pathogenen Tula Virus (TULV) nicht
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nachgewiesen werden. Eine Aktivierung des zentralen Transkriptionsfakors NFκB
wurde darüber hinaus ebenso wenig beobachtet wie die Degradierung seines
zytoplasmatischen Inhibitors IκB-α. Des Weiteren konnte auch keine eindeutig
erhöhte Expression der Zelladhäsionsmolekülen ICAM-1 oder VCAM-1 auf der
Oberfläche von HTNV- oder TULV-infizierten Endothelzellen festgestellt werden.
Demnach gehören sowohl die pathogenen wie auch die weniger pathogenen
Hantaviren vermutlich nicht zu den auslösenden Faktoren von Signalkaskaden, die
grundsätzlich im Zusammenhang mit entzündlichen Prozessen stehen.
Die durch eine Infektion ausgelöste angeborene Immunantwort der HUVEC
wurde untersucht, wobei insbesondere die Reaktionen auf eine Infektion mit HTNV
oder TULV miteinander verglichen wurden. Tatsächlich konnte sowohl in HTNV- wie
auch in TULV-infizierten HUVEC eine deutlich gesteigerte Expression von Antigen-
präsentierenden Molekülen beobachtet werden. Dabei war das weniger pathogene
TULV sogar noch effizienter in der Lage, die Expression der Klasse I HLA-Moleküle
zu induzieren. Interessanterweise löste dagegen eine Infektion mit dem pathogenen
HTNV die Freisetzung von Interferon (IFN)-β in den Zellkulturüberstand aus,
wohingegen das bei TULV-infizierten Endothelzellen kaum zu beobachten war.
Nichtsdestotrotz konnte die Induktion der Klasse I HLA-Moleküle in beiden Fällen
durch neutralisierende Antikörper gegen IFN-β blockiert werden. Das antiviral
wirksame MxA-Protein jedoch, welches die Replikation der Hantaviren behindert,
konnte in TULV-infizierten Endothelzellen bereits 16 Stunden nach der Infektion
nachgewiesen werden, was bei HTNV-infizierten Zellen erst nach 48 Stunden
gelang. Dementsprechend replizierte sich das TULV deutlich weniger effizient als
das HTNV in humanen Endothelzellen, wobei allerdings nach zwei Tagen der
Infektion ein deutlicher Titerabfall auch hier zu beobachten war. Beide Hantaviren
waren jedoch gleichermaßen in der Lage, sich in Vero-Zellen zu replizieren, denen
eine IFN-induzierte MxA-Antwort fehlt. Insgesamt legen die hier gezeigten
Ergebnisse nahe, dass die verspätete Induktion des antiviral wirksamen MxA-
Proteins in HTNV-infizierten HUVEC dazu führt, dass sich das Virus erfolgreich im






The Korean War in the 1950s was of pivotal importance for the recognition of
hantaviruses: More than 3000 soldiers from the United Nations fell ill with Korean
hemorrhagic fever (KHF). This febrile illness with renal failure and shock, frequently
accompanied by hemorrhagic manifestations, was associated with a case fatality rate
of about 5 to 10 % [Smadel J.E., 53]. The outbreak attracted world attention. Despite
intensive research the origin of this disease remained obscure. However, it became
clear that this was not a new disease and it was recognised that there were close
similarities to the long known hemorrhagic fever with renal syndrome (HFRS). It was
not until 1978, though, when a new virus was detected in the lungs of infected
Apodemus agrarius using convalescent sera from KHF patients. Hantaan virus,
named after the Hantaan river in Korea, was successfully propagated in its rodent
hosts and eventually isolated in cell culture in 1981 [French, 81; Lee, 78].
In 1993 an accumulation of cases of fatal respiratory distress of unknown origin
was documented in the Four Corners region in the USA. Unexpectedly, sera from
patients reacted with hantaviral antigen [Nichol, 93]. These findings boostered the
research efforts and eventually led to the identification of several new hantaviruses
[Ksiazek, 95; Schmaljohn, 95] as causative agents of the hantavirus cardiopulmonary
syndrome (HCPS).
Currently, these two human diseases are associated with a hantavirus infection:
HFRS together with its milder form referred as nephropathia epidemica (NE) and
HCPS.
1.1.2 Virology
Taxonomic status and genetic organisation.
Several of the most important human pathogens in the family of Bunyaviridae
are included within the separate genus Hantavirus. Like all members of this family
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hantaviruses have a segmented RNA genome. All three negative sense, single-
stranded segments encode only one protein, although minor open reading frames
have been identified [Jonsson, 01]. The large (L) segment encodes the viral
polymerase, whereas the medium (M) segment codes for a polyprotein cleaved
cotranslationally into two surface glycoproteins, termed G1 and G2. The nucleo (N)
protein, forming the nucleocapsid, is encoded by the small (S) segment [Schmaljohn,
96]. Hantaviruses carried by Arvicolinae and Sigmodontinae rodents, but not those
carried by Murinae rodents, possess an open reading frame of not yet clearly defined
functionality in their S segment [Bowen, 95; Plyusnin, 94]. On the basis of the
nucleotide sequences, mainly of the M and S segments, hantaviruses can be
serologically classified. In addition, the focus reduction neutralisation test (FRNT)
provides an efficient means for the serotyping of hantavirus-specific neutralising
antibodies in infected persons [Heider, 01].
At least 30 hantaviruses have been found [Hart, 99; Kanerva, 98]. Only about
half of these viruses have been isolated in cell culture so far, others have been
identified by their genetic sequences.
Morphology.
By electron microscopy, hantaviruses appear to be spherical in shape with an
average diameter of about 100 nm. The granulofilamentous interior composed of
ribonucleocapsids is surrounded by a lipid bilayered membrane. Two glycoproteins,
designated G1 and G2, are incorporated within the lipid envelope [Gonzalez-
Scarano, 96].
The morphogenesis of hantaviruses has not yet been clearly defined. The virus
assembly is thought to begin with the cotranslational cleavage of the polyprotein
encoded by the M segment into two glycoproteins. Following glycosylation and
folding of G1 and G2 inside the Golgi complex, the proteins are retained and
gradually accumulate. The N protein forming the nucleocapsid is expressed in the
cytoplasm. In fact, hantaviral antigen is generally not detected on the surface of an
infected cell but is located in the perinuclear region. Together with the viral RNA
segments the nucleocapsid is targeted to the Golgi complex, probably by specific
recognition of the cytoplasmic part of the glycoproteins, where virus particles finally
budd into the Golgi cisternae [Ravkov, 01].
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Natural reservoir hosts.
Hantaviruses are usually closely associated with a particular reservoir host
(Figure 1). The geographic distribution of the host determines the distribution of the
virus and, accordingly, of human disease. Serological and virological studies, i.e. cell
culture or genome detection, have shown evidence of hantaviruses in rodents almost



















Figure 1. Phylogenetic relationship of hantaviruses.
Illustration of the parallel phylogeny between hantaviruses and their rodent hosts.The subfamilies of
hantaviral rodent hosts (Murinae, Arvicolinae and Sigmodontinae) and the insectivore host are
designated by the shaded regions. Genetically related rodents carry genetically similar hantaviruses.
Positions and lengths of lines do not imply precise phylogenetic relationships. After: McCaughey and
Hart, 2000 (modified).
Roughly, hantaviruses are subdivided into New World and Old World
hantaviruses. Hantavirus species originating from New World rodents of the
subfamily Sigmodontinae (New World rats and mice) are associated with HCPS.
SinNombre (SNV) carried by Peromyscus maniculatus, a Sigmodontinae rodent, was
responsible for the initial outbreak in the Four Corners area. Rodents from the
subfamily Murinae (Old World rats and mice) carry hantaviruses which are
associated with HFRS. Dobrava virus (DOBV), Hantaan virus (HTNV), or Seoul virus
(SEOV), well-studied representatives of this genetic group, are found primarily in the
Balkan region and in East Asia. Viruses hosted by the subfamily Arvicolinae (Old
World voles) including Puumala (PUUV) are associated with NE, the milder form of
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HFRS. Though Tula (TULV) and Prospekt Hill (PHV), viruses generally accepted to
be rather nonpathogenic [Geimonen, 02; Schultze, 02; Yanagihara, 90], are both
carried by Arvicolinae rodents, their distribution differs greatly. While Microtus arvalis,
carrier of TULV, is found in Europe, Prospect Hill and its carrier Microtus
pennsylvaticus are found in North America only [McCaughey, 00; Schmaljohn, 97].
Hantavirus infection in rodent hosts is asymptomatic and often long-lasting.
Infectious virus is excreted with urine and other excreta for months or even years
[Bernshtein, 99; Kanerva, 98]. During persistent infection in adult rodents viral
antigen can be detected in endothelial cells and in many tissues including lung and
kidney, heart and spleen [Botten, 00; Green, 98]. However, the presence of
hantavirus in an individual rodent host does not provoke survival disadvantage.
In the Eurasian region human infections with hantaviruses are associated with a
broad range of clinical presentations ranging from very severe, even lethal cases of
HFRS after an infection with HTNV to mostly asymptomatic TULV infections.
Transmission.
Hantaviruses, unlike viruses of other bunyavirus genera, are not transmitted by
arthropod vectors. Instead, they persistently infect rodents of the family Muridae
(order Rodentia). Transmission among rodents and to humans occurs generally via
the respiratory route by inhalation of aerosols from rodent excreta [Kanerva, 98],
although infection has been transmitted by rodent bites as well [Gonzalez, 84; Hart,
99]. Therefore, the respiratory tract is probably the primary site of replication for
hantaviruses both in rodent host and humans [McCaughey, 00]. Transmission to man
is a dead end for the virus since humans do not secrete hantaviruses in large
amounts during infection [Clement, 03]. Moreover, person-to-person transmission
has so far been documented in individual cases only [Padula, 98; Pinna, 04; Wells,
97].
1.1.3 Infection in man
For most hantavirus infections in humans, asymptomatic or mild infections with
unspecific manifestations outnumber the infections with severe symptoms. An
estimation of the number of cases is therefore difficult. However, about 60 000 to 100
000 hospitalised cases are reported annually world-wide [Krüger, 01; Vapalahti, 03].
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Clinical features.
The clinical presentation of human hantavirus disease varies with the virus,
disease type (HFRS or HCPS) and probably with human host characteristics as well.
Accordingly, case fatality rates range from 0.1% in NE, up to 15 % in HFRS and 30 to
50 % in HCPS [Lee, 96; Schmaljohn, 97]. Namely for nephropathia epidemica (NE)
caused by infection with PUUV host factors affecting disease severity have been
described. Patients with HLA-DRB1*0301 and HLA-B8 alleles are associated with
severe NE, whereas those with HLA-B27 show a milder course of disease [Plyusnin,
97].
The most severe form of HFRS is caused by Hantaan virus in Asia and Dobrava
virus in East Europe. It is characterised by an acute triad of fever, haemorrhage and
renal failure. In severe cases capillary permeability and vascular leakage lead to
shock and cardiovascular collapse [Tkachenko, 91].
HCPS has a very different presentation from HFRS, although laboratory
findings are basically similar to those in HFRS [Zaki, 95]. Renal involvement is rare
and haemorrhagic manifestations are uncommon. In addition to severe respiratory
insufficiency caused by pulmonary oedema, shock and myocardial dysfunction also
account for the high case fatality of HCPS [Nichol, 96].
However, clinical features of HFRS and HCPS each run across spectra of
presentation and severity. There can be pulmonary involvment in NE [Kanerva, 96b]
and HFRS-like symptoms in HCPS [Hjelle, 96]. The pathogenic potential of some
hantaviruses is not clear at present [McCaughey, 00; Schultze, 02]. While PHV or
TULV are usually considered to be nonpathogenic to humans, a recent report could
clearly associate a case of HFRS with pulmonary involvement with TULV infection,
which should therefore be considered as a hantavirus with potential pathogenicity for
humans [Klempa, 03].
Pathological findings in humans.
The endothelium represents a primary target for hantavirus infections.
Endothelial cells, however, do not seem to be morphologically damaged in HCPS or
HFRS patients [Pensiero, 92; Yanagihara, 90; Zaki, 95]. Still, capillary leakage is a
common feature for both diseases. In all organs the inflammatory response seems
rather mild and only slight mononuclear cell infiltrates are seen [Kanerva, 98]. The
mechanisms ultimately causing increased endothelial permeability in hantavirus
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infections are still unknown. However, subtle morphological changes might disturb
the function and integrity of endothelial cells lining the capillaries, rather than gross
damage induced by the virus directly. According to this, immunological and chemical
mediators of inflammation should be considered to play a major role in hantavirus
pathogenesis [Cosgriff, 91; Zaki, 95].
1.1.4 Infection in cell culture
Hantaviruses infect a broad range of different cell types and generate persistent
infections in most cell cultures including continuous cell lines like A549 (lung
carcinoma) or primary endothelial cells and monocytes/macrophages as well as Vero
cells [Kitamura, 83; Nagai, 85; Pensiero, 92; Yanagihara, 90]. Without causing visible
cytopathic effects they replicate in vitro in the cytoplasm of the host cell and
apparently do not disturb the protein synthesis. In this regard, differences between
pathogenic and nonpathogenic hantaviruses are not obvious. It is therefore not clear
how hantavirus infections cause disease [Kanerva, 98]. Since direct viral effects are
not apparent in either case, indirect effects like cellular mediators released from
infected cells should be considered as triggers for hantavirus pathogenesis.
Moreover, interactions between target cells of a hantavirus infection like endothelial
cells on the one hand and cells of the immune system on the other hand might be the
clue to understanding hantavirus pathogenesis.
Generally, hantaviruses grow comparatively slowly and it takes several days to
reach complete infection in cell culture. The delayed growth depends mainly upon the
adaptation level of the virus to the cell type used [Temonen, 93; Yanagihara, 90].
Several blind passages are required to isolate virus from rodents or humans in cell
culture during which the virus adapts to the cell culture. Still, isolation of infectious
virus is often uneffective. In fact, only few cases of successful propagation of virus
derived from humans have been reported so far [Avsic-Zupanc, 94; Galeno, 02; Juto,
97].
1.1.5 Safety aspects
Biosafety level (BSL) 3 is suitable for work with infectious agents which may
cause serious or potentially lethal diseases as a result of inhalation [CDC, 99].
Therefore, in laboratory facilities all laboratory work involving the propagation of
hantaviruses in cell culture should be conducted in BSL 3 conditions. Nevertheless,
reports about laboratory-aquired hantavirus disease are well known throughout the
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world. Human disease caused by contact with naturally or experimentally infected
rodents as well as by hantaviruses present in continuous cell lines has been reported
[Lloyd, 84; Lloyd, 86]. It is therefore of great importance not only to handle the virus
according to its potential hazard but to use appropiate inactivation procedures if
further analysis are required outside the BSL 3-laboratory. Like other lipid-enveloped
viruses, hantaviruses are susceptible to most disinfectants like peracetic acid or
active chlorine [Prince, 91]. However, these agents are usually not suitable for
subsequent cell biological, virological and immunological investigations and have to
be substituted.
1.2 Endothelial cells
Since hantaviruses are derived from aerosolised rodent excreta the respiratory
tract is probably the primary site of infection and replication. Moreover, main
symptoms in human disease are based upon vascular dysfunction. Therefore,
endothelial cells have been postulated to be the main target in a hantavirus infection
in vivo [Kanerva, 98]. In fact, viral antigen has been demonstrated in endothelial cells
of capillaries and blood vessels of the lung during the early phase of disease [Zaki,
95].
1.2.1 Structure and function of the endothelium
The endothelium represents an important boundary layer between the lumen of
blood vessel and tissues. As a single-cell layer it covers the surface of blood vessels
and regulates exchanges between the bloodstream and the surrounding tissues. The
endothelium is therefore involved in the structural and functional regulation of
homeostasis and permeability [Short, 98].
Cytoskeleton.
For proper function of the endothelium its structural integrity is required and
mainly ensured by cell-to-cell junctions between endothelial cells. Adherence
junctions are necessary for the first contact between endothelial cells by
mechanically holding the cells together. The main structures involved in the
maintenance of the barrier function, however, are the tight junctions [Lum, 96], which
are responsible for sealing adjacent cells. At these contact sites, transmembrane
receptors like integrins are linked to the actin skeleton, anchoring the endothelial
cells to the extracellular matrix and therewith maintaining endothelial integrity.
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Changes in the morphology of endothelial cells such as the formation of stress
fibers might be a first hint to an infection. The actin cytoskeleton is largely
responsible for establishing the shape of the cell and for controlling the changes in
shape that occur when a cell is exposed to stress stimuli, e.g. shear stress. Integrins
function as transmembrane linkers which mediate bidirectional interactions between
the extracellular matrix and the actin cytoskeleton. They also function as signal
transducers, activating various intracellular signalling pathways, including the inositol
phospholipid pathway, when activated. Moreover, chemical stimuli, like cytokines or
inflammatory mediators, induce signalling pathways in endothelial cells to modulate
vascular biology.
Integrins.
These heterodimeric receptors composed of α and β subunits mediate cell-cell
adhesion, cell migration and recognition of the extracellular matrix [Hynes, 92b;
Lampugnani, 91]. The cytoplasmic domains of integrins transduce signals from both
the inside and outside of the cell and regulate the integrin-mediated signalling events
[Liu, 00].
Integrins are abundant surface receptors of endothelial cells and platelets
[Hynes, 92b]. They were recently found to bind receptors that regulate vascular
permeability [Short, 98]. Integrins are also linked to intracellular cytoskeletal elements
like actin, which play a role in the migration process on the extracellular matrix
[Hynes, 92a; Lampugnani, 91]. Integrin-directed cellular migration is another
important aspect of endothelial cell function in the maintenance of vascular integrity
[Kevil, 98].
The cellular entry of pathogenic hantaviruses is facilitated by specific β3
integrins, while nonpathogenic PHV enters the cell via β1 integrins [Gavrilovskaya,
98; Gavrilovskaya, 99]. Both integrins are expressed on the surface of endothelial
cells and macrophages, and hantaviruses are known to predominantly infect these
cells [Gonzalez-Scarano, 96; Nolte, 95; Pensiero, 92]. The increased vascular
permeability observed in hantavirus disease might be connected to the interaction of
hantaviruses with integrins [Gavrilovskaya, 98; Gavrilovskaya, 99; Gavrilovskaya,
02].
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Interactions of pathogenic hantaviruses with β3 integrins are considered
potential triggers of endothelial dysfunction and thereby contributing to increased
vascular permeability observed in hantavirus disease.
1.2.2 Inflammatory pathways in the endothelium
The surface of the endothelium is exposed to all kinds of pathogens. Adhesion
of pathogens to endothelial cells is often, albeit not necessarily, sufficient to activate
the endothelium. This activation, however, plays a major role in the pathophysiology
of inflammatory processes eventually leading to endothelial dysfunction.
The complex series of events which occurs during inflammation include
vascular changes and cellular events. Enhanced vascular permeability and migration
of leukocytes through vessel walls into adjacent tissues characterise inflammatory
reactions. They are mediated by chemical substances such as cytokines, in particular
interferons, initially derived from activated lymphocytes and monocytes. Endothelial
cells, also activated during the early phase of the inflammatory response, show
increased expression of adhesion molecules which facilitate adherence of
inflammatory cells to the endothelium [Johnson-Leger, 03]. Subsequent signalling
cascades within the endothelial cells eventually lead to the activation of the NFκB
pathway resulting in the expression of proteins such as receptors required for
immune recognition or proteins involved in antigen presentation as well as cytokines
and chemokines [Hiscott, 01]. However, such inflammatory stimuli employed in the
NFκB pathway induce yet another separate pathway eventually leading to the
activation of mitogen-activated protein (MAP) kinases. This highly conserved family
of kinases is one of the major mechanisms used by human cells to transduce
extracellular signals into intracellular responses [Robinson, 97].
Cytokines.
Endothelial dysfunction is characterised by increased permeability caused
either by direct endothelial infection or by rather indirect effects like the production of
various cytokines by activated leukocytes, for instance. In response to these
inflammatory mediators, second messenger molecules modulate the actin-based
cytoskeletal system of the endothelial cells and eventually lead to the disruption of
the endothelial barrier integrity. This modulation process involves phosphorylation of
linkage proteins at the junction sites leading to the reorganisation of the actin
skeleton [Lum, 96].
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Proinflammatory cytokines such as interleukin (IL)-1α produced specifically at
the site of infection mediate the activation of leukocyte integrins, while the ligands of
these integrins, namely adhesion molecules Intercellular adhesion molecule (ICAM)-
1 and vascular cell adhesion molecule (VCAM)-1, are upregulated on the surface of
the inflamed endothelium [De Caterina, 01]. Upon stimulation endothelial cells
themselves are able to release cytokines that may further promote the inflammatory
response thereby amplifying the host immune response. IL-6 is one such
proinflammatory cytokine, produced by various cell types including monocytes,
macrophages and endothelial cells. It interacts with its membrane receptor and a
signaltransducing glycoprotein eventually resulting in activation of MAP kinases
[Legendre, 03].
The endothelium is therefore considered both a source of and a target for
inflammation [Hack, 01].
Interferons.
Amongst others the family of cytokines comprises interferons (IFN) which are
mainly known for their antiviral activities against a wide spectrum of viruses. They are
proteins produced by cells in response to virus infection and a number of other
stimuli including nucleic acids, synthetic oligonucleotides (poly I:C) or bacterial
lipopolysaccharides [Paludan, 00]. These cytokines upregulate the expression of
antigen presenting molecules such as human leukocyte antigen (HLA) class I which
are recognised by cytotoxic CD8-positive T lymphocytes thus eliminating virus-
infected cells. On exposure to an IFN cells develop an antiviral state in which a
network of genes encoding factors with direct antiviral activity is stimulated. IFN,
however, also affect cell growth and cell function (Figure 2). Type-1 IFN are
synthesised not only in response to virus infection but are also produced at basal
levels in the absence of a viral infection [Taniguchi, 01].
The three main human IFN, can be subdivided into type-1 and type-2 IFN. IFN-
α and IFN-β, so called type-1 IFN, are thought to bind to the same receptor on the
cell surface of target cells. This receptor differs from that of IFN-γ representing type-2
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Figure 2. Molecular mechanisms of type 1 IFN-induced antiviral pathways.
Interferons (IFN) are ubiquitously expressed cytokines that interfere with virus replication within
different cell types by activating a number of host genes and several parallel antiviral pathways. Two
major intracellular actors of type-1 IFN-induced antiviral states are ribonucleic acid-dependent protein
kinase (PKR) and 2'-5'-oligoadenylate synthetase (OAS), both being induced by type-1 IFN and
activated by viral double stranded RNA. In addition, MxA proteins have also been implicated in type-1
IFN induced antiviral responses to some RNA viruses. Viruses, in turn, have evolved different
strategies to escape control imposed by type-1 IFN and by type-1 IFN-induced antiviral factors. This
includes the disruption of dsRNA and IFN receptor/Janus kinase (JAK) and signal transducer of
activation and transcription (STAT) signalling events, the inhibition of interferon regulatory factors
(IRF) and major histocompatibility complex (MHC) functions. The fatal outcome of virus infection is
determined by complex interactions between viral virulence factors and cellular antiviral type-1 IFN-
inducible factors. From: Katze et al., 2002 (modified).
IFN-α is produced by monocytes and macrophages, lymphoblastoid cells,
fibroblasts, and a number of other cell types. IFN-β, a strictly species-specific IFN, is
produced mainly by fibroblasts, epithelial and endothelial cells. It is involved in the
regulation of unspecific humoral immune responses and immune responses against
viral infections. IFN-β increases the expression of HLA class I molecules and blocks
the expression of HLA class II molecules stimulated by IFN-γ [Lu, 95]. Additionally,
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IFN-β stimulates the activity of natural killer cells (NK cells) and hence also antibody-
dependent cytotoxicity. IFN-γ, at last, is an important immunomodulatory cytokine
produced by activated T lymphocytes and NK cells, but not by endothelial cells.
Expression of IFN-α and IFN-β is controlled by the transcription factor NFκB
together with Interferon regulatory factors (IRF) [Hiscott, 95]. Virus-induced
posttranslational phosphorylation of IRF-3 is thought to stimulate IFN-β production.
Secreted IFN-β then acts through the JAK-STAT pathway to stimulate the production
of a another member of the IRF family, namely IRF-7, which in turn contributes to the
transcriptional induction of different IFN-genes [Hiscott, 99; Marie, 98].
However, this complex interplay between the endothelium and the immune
system during an inflammatory response or after a viral infection is still unexplained
to a considerable extent.
Adhesion molecules.
Pathogens may use endothelial signalling pathways by binding to cell surface
receptors and alter endothelial function by affecting endothelial monolayer integrity.
These interactions are triggered by the characteristic properties of endothelial cells
such as the expression of cell surface molecules, namely of the selectin and ICAM
family.
Exposure to proinflammatory cytokines results in a massive increase in
adhesion molecule expression on the surface of endothelial cells. Transmembrane
glycoproteins of the selectin family, namely E-selectin, mediate the very first steps of
leukocyte adhesion to the endothelium. In fact, in vitro induced upregulation of E-
selectin molecules is transient and peaks already at six hours after stimulation,
returning to baseline after 24 hours [Kuhns, 95]. E-selectin usually acts as signalling
molecule for cell-cell interactions in the processes of vascular permeability and
inflammation.
While E-selectin is unique to the endothelium, ICAM-1 and VCAM-1 are
expressed on a variety of cell types including leukocytes, epithelial and endothelial
cells. As cell surface glycoproteins of the immunoglobulin superfamily they act as
mediators of firm adhesion between leukocytes and endothelium during immune
responses. Accordingly, expression levels of ICAM-1 reach a maximum after 12 to 20
hours after stimulation and remain elevated for at least another 48 hours [Reinhart,
02].
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Thus, the different expression kinetics of these adhesion molecules underline
their diverse role in inflammatory processes observed in the endothelium.
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Figure 3. Mechanisms of NFκB activation.
NFκB is sequestered in the cytoplasm by the inhibitory IκB protein. Stimulation by a diverse array of
pathogens and other inducers including viruses, lipopolysaccharide (LPS), tumor necrosis factor
(TNF), interleukin-1 (IL-1) and stress-inducing agents leads to the activation of signalling cascades.
They culminate with the activation of the IκB kinase (IKK) complex and phosphorylation of the inhibitor
IκB. NFκB subunits which bind to DNA are released and translocate into the nucleus where they
transactivate NFκB-responsive genes.
NFκB is a transcription factor expressed in numerous different cell types after
stimulation or cell activation by a wide variety of stimuli like cytokines, crosslinking of
surface molecules, viruses or viral proteins, to name only a few. A variety of different
genes contains NFκB binding sites in their promoters. Cytokines and their receptors,
cell adhesion molecules and many other proteins involved in various processes,
including immune responses and inflammation, are important proteins encoded by
NFκB-responsive genes.
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NFκB activities are controlled by inhibitory proteins (Figure 3). Inactive NFκB is
located in the cytoplasm of cells where it is complexed by the inhibitor of NFκB (IκB).
Signal-dependent phosphorylation results in the ubiquitination of IκB protein and
targets the cytoplasmic inhibitor to the ubiquitin-proteasome pathway where it is
degraded [Chen, 95]. Dissociation of IκB from NFκB results in the translocation of the
released transcription factor into the nucleus.
Mitogen-activated protein kinases.
Cells respond to extracellular signals by transmitting intracellular instructions
and therewith coordinate an appropriate reaction. Usually, such reactions are
accomplished through gene regulation, either downregulation or upregulation as in
the increased expression of major HLA class II antigens leading to an amplified
inflammatory response.
Alternatively, at the molecular level signal transduction is often achieved by
activation or inhibition of regulatory proteins through phosphorylation by protein
kinases. MAP kinases represent an important and rapid signalling cascade to
transduce such extracellular signals into cellular responses (Figure 4).
In humans, three major groups of MAP kinases have been identified: the extra-
cellular signal–regulated kinases (ERK or p42/44), the p38 MAP kinases, and the c-
Jun amino-terminal kinases [Schaeffer, 99].
p38 is recognised as the MAP kinase that is activated in response to
inflammatory stimuli. LPS, TNFα and IL-1 are exemplary stimuli inducing p38
activation in monocytes and endothelial cells eventually resulting in the
proinflammatory phenotype of these cells. Namely endothelial E-selectin and COX-2,
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Figure 4. The mitogen-activated protein (MAP) kinase activation cascade.
The classic MAP kinase (MAPK) cascade consists of three intracellular protein kinase activation steps.
Initiation involves the activation of MAP kinase kinase kinase (MAPKKK), including TGF-activated
kinase (TAK), leucine zipper-bearing kinase (DLK), mixed lineage kinase (MLK) or MAP/ERK kinase
kinase (MEKK). These Ser/Thr kinases phosphorylate and thereby activate MAP kinase kinases
(MAPKK). Subsequently, MAPKK, such as MAP kinase kinase (MKK) and MAP/ERK kinase (MEK),
activate MAP kinases by phosphorylation on two threonine and tyrosine residues. MAP kinases like
extracellular signal-regulated kinase (ERK), stress-activated protein kinase (SAPK), c-Jun N-terminal
(JNK) or big MAPK (BMK), as proline-directed protein kinases then activate other protein kinases and
transcription factors such as the STAT family [Aaronson, 02; Arbabi, 02].
Thus, p38 is classically known as “stress-induced” MAP kinase, whereas
p42/44, or ERK, is thought to be predominantly involved in the regulation of cell
proliferation [Most, 03]. p42/44 is activated in response to LPS and various growth
factors like TGF or PDGF. Moreover, adherence of monocytes and endothelial cells
activates p42/44 through integrin-mediated phosphorylation [Clark, 98].
1.2.3 HUVEC as an infection model?
Still, there is no appropriate disease model to study either HCPS or HFRS.
Even though hantaviruses cause lethal disease in newborn mice [Kim, 85], the
disease does not mirror the disease observed in humans. Only recently, a small
animal disease model for HCPS has been proposed [Hooper, 01]. However, the
described lethal disease model in adult Syrian hamsters has been established for
Andes virus only. HFRS-inducing hantaviruses, in contrast, do not cause disease in
hamsters even when infected with high doses [Hooper, 01]. However, it has been
demonstrated recently, that infection of cynomolgus macaques by wild-type PUUV
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resulted in typical signs of HFRS including lethargy, anorexia, proteinuria and
hematuria as well as cytokine responses, and virus-specific immune responses
mimicked those seen in humans [Klingström, 02].
This lack of a suitable small animal model in addition to the general advantages
that an in vitro model offers, such as the relatively simple and inexpensive realisation
of a large number of experiments, justifies the use of such an infection model.
Additionally, experiments can be specifically focused on a single cell type of interest.
Endothelial cells constitute not only the first barrier between the blood and the
extravascular space. The endothelium also contributes significantly to a wide variety
of cardiovascular functions including the regulation of permeability, blood pressure,
transmigration of leukocytes and exchange of oxygen, carbon dioxide as well as
metabolites. Endothelial integrity is required for proper function of the endothelium
and mainly ensured by endothelial cell-cell junctions. Moreover, endothelial cells are
target for and participate in immune reactions. For this reason, human endothelial
cells are an obvious cell type to study hantavirus pathogenesis. Direct viral effects
can be analysed and indirect effects such as soluble factors secreted by infected
cells can be investigated.
While continuous cell lines exhibit characteristics that are similar to those of
primary cultures, immortalised cells have aquired genetic changes that might alter
cellular function. Therefore, primary cells, although less uniform and perpetual,
provide a suitable means to study pathogenesis in a near-natural manner. HUVEC
are such primary endothelial cells isolated from human umbilical cord veins [Jaffe,
73].
1.3 Immune mechanisms in hantavirus pathogenesis
The role of the immune response in the pathogenesis of human hantavirus
infections is not entirely clear. Infection leads to the generation of antigen-specific
activated T lymphocytes [Van Epps, 99; Van Epps, 02]. In both HCPS and HFRS,
hantavirus antigen-specific cellular and humoral responses are present at the clinical
onset of the disease [Peters, 99]. Besides observed changes in the cellular immune
response such as increased concentrations of CD8-positive cells, increased levels of
immune mediators such as TNFα or IFN-γ can be detected in patient’s blood
[Markotic, 99; Vapalahti, 01]. These observations, together with the obvious lack of
any cytopathic disruption of the endothelium, support a role for immune-mediated




Once cells are successfully infected with hantaviruses their replication in cell
culture is subsequently restricted by IFN induced by the viral infection itself
[Pensiero, 92; Temonen, 95]. Still, hantaviruses are not particularly effective IFN
inducers as shown by in vitro infections of human macrophages or serum levels of
patient with HFRS [Krakauer, 94; Temonen, 95]. Externally added type I IFN,
however, is likewise able to inhibit the replication in infected cells [Kanerva, 98; Nam,
03; Temonen, 95].
Many of the diverse biological effects of IFN are based on the binding of an IFN
to its receptor. Subsequently, a rapid expression of genes that contain a conserved
enhancer element, the so called Interferon Stimulated Response Element or ISRE, is
induced. Genes containing an ISRE represent components of the antiviral defence
such as OAS and the dsRNA activated PKR, cell surface proteins such as ICAM-1 or
HLA class I and II molecules. The induced protein kinase, for instance, inactivates
the eukaryotic initiation factor eIF-2 and thus inhibits the synthesis of new viral
proteins. The expression of OAS leads to products which themselves activate
endonucleases that in turn degrade viral RNAs [Williams, 91]. In fact, several cellular
genes associated with an antiviral response such as IFN-induced OAS are
upregulated after infection of human endothelial as well as human lung epithelial
cells with hantaviruses [Geimonen, 02; Nam, 03].
Yet another IFN-regulated pathway involved in the cellular protection against
viral infections includes so-called Mx proteins. These IFN-induced large GTPases
interfere with the replication of a broad range of RNA viruses by perturbing the
intracellular movement and functions of viral proteins [Frese, 96]. Recently, it has
been shown in cell culture experiments that several members of the Bunyaviridae
family are in fact inhibited by the Mx protein, including Puumala (PUUV), Hantaan
(HTNV), and Sin Nombre virus (SNV) as well as Tula virus (TULV) [Kanerva, 96a].
Furthermore, it has been demonstrate that the human MxA protein intracellularly
sequesters the viral N protein of La Crosse virus, another member of the
Bunyaviridae thereby trapping an essential virus component in cytoplasmic
inclusions. It is then unavailable for the generation of new virus particles [Kochs, 02].
For a complete inhibition of PUUV or TULV replication, however, high Mx expression
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levels are required [Kanerva, 96a]. This could also be responsible for the relative
inefficiency of IFN-α therapy in HTNV-infected humans [Gui, 87].
Other cytokines and chemokines.
In both HFRS and HCPS there is evidence of a strong cellular immune
response, characterised by elevated levels of IFN-γ and TNFα in the blood of patients
[Khaiboullina, 02; Peters, 99]. Apart from the induction of these cytokines in vivo,
however, the selective induction of the chemokines RANTES (regulated on
activation, normal T cells expressed and secreted) and interferon-inducible protein
(IP)-10 in human microvascular endothelial cells after infection with HTNV may
provide a clue to the role of the specific immune response in hantavirus pathogenesis
[Sundstrom, 01]. Both RANTES and IP-10 are predominantely chemotactic for
leukocytes, and IP-10 is essential for the development of a protective TH1 immune
response [Liu, 00]. Thereby, these chemokines provide a mechanism by which
hantavirus infection enhance recruitment of activated monocytes and lymphocytes to
the infected endothelium. These cells are indeed the major immune cell types found
in lungs of HCPS patients as well as in kidney biopsies of HFRS patients [Cosgriff,
91; Zaki, 95].
Yet another protein involved in vascular permeability, VEGF, was recently
shown to be upregulated after an infection with HTNV in human endothelial cells
[Sundstrom, 01; Khaiboullina, 02]. As a potent chemoattractant for monocytes and as
a highly specific enhancer of microvascular permeability, it could also play an
important role in the immune-mediated endothelial dysfunction observed after
hantavirus infection.
Apoptotic cell death.
Multicellular organisms can employ a number of defence strategies to combat
viral replication, the most dramatic being clearance of infected cells by apoptotic
processes. The overall cost to the viability of an organism of losing infected cells by
apoptosis may be small if the dying cells can be substituted.
Apoptosis, or programmed cell death, is a regulated physiological process
leading to cell death characterised by cell shrinkage, membrane blebbing and DNA
fragmentation. This active process involves the coordinated activity of a variety of
proteins, separated into activators, effectors, and negative regulators, which are
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brought together in different signalling pathways. In fact, cellular survival requires
active inhibition of apoptosis.
Akt, referred to as protein kinase B (PKB) or Rac, plays a critical role in
controlling the balance between survival and apoptosis. This protein kinase is
phosphorylated and activated by various growth and survival factors including
cytokines like IL-6, which is produced in response to viral infections, or VEGF
[Mogensen, 01]. Akt then functions to promote cell survival by inhibiting apoptosis by
phosphorylating and thereby inactivating several targets such as caspase-9. In fact, it
has been shown recently, that Akt signalling promotes endothelial cell survival by
inhibiting MAP kinase p38-dependent apoptosis. Thus, cross-talk between Akt and
p38 pathways may regulate the balance between cell survival and apoptosis and is a
new mechanism to explain the survival actions of Akt [Gratton, 01].
Alternatively, Epstein-Barr virus (EBV) or human herpes virus-8 (HHV-8) have
been shown to express bcl-2 homologues and thereby promote cell survival by
blocking apoptosis [Korsmeyer, 99]. The antiapoptotic bcl-2 has the ability to exert a
survival function in response to a wide range of apoptotic stimuli by blocking
mitochondrial release of cytochrome c [Yang, 97; Kluck, 97].
1.3.2 Humoral and cellular immune response
Humoral immune responses to hantavirus antigens have been studied
extensively. During the early phase of the disease an IgM response against all
structural proteins of the virus can be detected in the blood of HFRS patients. The N
protein, however, is presumed to be the major target of this early antibody response.
Levels of IgM antibodies then decline while levels of virus-specific IgG antibodies
increase simultaneously [Groen, 92; Lundkvist, 93]. Antibody titers against the two
envelope glycoproteins, G1 and G2, then dominate over the N-specific antibody
response [Kanerva, 98]. Thus, IgG antibodies are mainly induced by the
glycoproteins G1 and G2, and it could be concluded that these proteins are major
inducers of the humoral immune response [Khaiboullina, 02].
Pathological manifestations seen during HFRS has been suggested to be the
result of virus-specific CTL responses [Van Epps, 02]. Increased numbers of
stimulated CD8-positive T lymphocytes have been observed in the blood from
patients with acute severe hantavirus-associated disease [Nolte, 95]. Surprisingly,
high frequencies of memory CD8-positive T lymphocytes can be found a long time
after the clinical hantavirus infection has resolved [Van Epps, 02]. Moreover, CD8-
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positive T lymphocytes have been detected in association with hantavirus-infected
lung endothelial cells by immunohistochemical analysis of specimens derived from
HCPS patients [Nolte, 95; Zaki, 95]. In kidney biopsies of patients with HFRS
infiltrating CD8-positive T lymphocytes have been localised near the tubuli
[Temonen, 96]. Finally, hantavirus-infected endothelial cells have been shown to
secrete chemokines that attract T lymphocytes [Sundstrom, 01].
Activation of antiviral T lymphocytes, particularly in a primary response,
depends critically on the proper function of dendritic cells. A growing number of
viruses such as human cytomegalovirus (CMV) or measles virus are known to infect
human dendritic cells and interfere with the function by a variety of mechanisms
[Fugier-Vivier, 97; Raftery, 01]. Interestingly, immunohistochemistry performed on
samples derived from HCPS patients demonstrated that hantavirus antigen
colocalises with follicular dendritic cells in the spleen and in lymph nodes [Zaki, 95].
This finding hinted at hantavirus replication in dendritic cells. A subsequent release of
proinflammatory cytokines such as TNFα and IFN-α could then enhance the
observed hantavirus-induced endothelial cell leakage. It is furthermore believed that
natural killer (NK) cells represent an important part of the innate immune response
against viral infection [Guidotti, 01]. The observed decrease in the number of NK
cells in the blood of HFRS patients [Lewis, 91; Linderholm, 93] might be due to the
migration of these cells into infected tissue. Specific cytokine signals produced by
infected cells then trigger the maturation of naive NK cells in situ into mature NK cells
[Matsukawa, 00].
Again, these findings suggest that cellular immune mechanisms may play a
more significant role than direct effects in the pathogenesis of endothelial dysfunction
induced by hantavirus.
1.3.3 Viral immune evasion
Viruses have evolved elegant mechanisms to evade detection and destruction
by the host’s immune system. Strategies of viral immune evasion are directed
towards the cellular and humoral immune response as well as innate immune
effector functions. Finally, some viruses have the additional capacity to hide from the
host’s immune defence by establishing latency.
Appropriate mechanisms comprise restriction of HLA class I molecules which
blocks the presentation of viral antigen thereby interfering with the cellular immune
response. The HLA antigen-presentation pathway itself can also be blocked by viral
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gene products at multiple levels. The spectrum of employed strategies ranges from
the retention of HLA class I molecules in subcellular compartments to interference
with proteasomal degradation to the prevention of peptide transport by the
transporter associated with antigen presentation (TAP) [Alcami, 00]. However,
disrupting the functionality of dendritic cells is yet another mechanism to impair the
host’s immune defence [Bhardwaj, 97].
On the other hand, downregulation of HLA class I molecules on the cell surface
results in elimination of the infected cell by natural killer cells [Ljunggren, 90].
Therefore, some viruses avoid natural killer cell-mediated killing by expression of
HLA homologues that function as viral dummies to prevent the expected cytotoxicity
[Farrell, 97]. Yet another strategy targets the IFN system, and in fact, this appears to
be a major strategy employed by different viruses to subvert the antiviral response
[Levy, 01; Vossen, 02]. Viruses have evolved mechanisms to inhibit IFN signalling by
disarming the host immune defence. In fact, many virus genomes contain "anti-
immune genes" that control the synthesis of host cell proteins, including cytokine
homologs and cytokine receptor homologs, for example.
The comparatively small coding capacites of hantaviruses, however, limit the
number and extent of potential immune evading mechanisms. In fact, little is known
about the precise interplay between hantaviruses and the host defence system. The
implication of this complex interplay on viral pathogenicity, viral clearance, viral
immunity and persistence is yet to be clarified.
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1.4 Objectives
Hemorrhagic fever viruses modify hemostatic mechanisms in two separate
ways. The first is through direct action on cells involved in vascular hemostasis, and
the second is through immunological and inflammatory pathways. However, the
mechanisms underlying virus-associated pathogenicity are largely unknown.
Therefore, the following questions concerning the immunopathogenesis of
hantavirus infections should be addressed in this study:
1. Are hantaviruses able to directly activate human endothelial cells?
The capacity of pathogenic and rather nonpathogenic hantaviruses to induce an
antiviral response in endothelial cells should be compared. For this purpose, the
growth of HTNV and TULV should be comparatively analysed in HUVEC and Vero
E6 cells. Expression of antigen presentation molecules and the production of type I
IFN in HTNV- and TULV-infected cells should be investigated. Moreover, induction of
the IFN-induced MxA protein by HTNV or TULV should be explored in HUVEC.
Furthermore, the analysis of virus-directed cellular responses such as general
induction of inflammatory pathways or specific induction of adhesion molecues
should provide insight into disease mechanisms. These data should facilitate an
essential understanding of virus-cell interactions that are likely to contribute to
disease.
2. Are human dendritic cells susceptible to hantavirus infection? How are they
affected by an infection with hantaviruses?
As dendritic cells and macrophages play a major role in the induction and
regulation of the innate and adaptive immune response, the tropism of these viruses
for the antigen-presenting cells (APC) should be studied. The susceptibility to an
infection as well as the ability to support a productive infection should be determined.
Prior to the infection experiments appropriate safety precautions ought to be
established. Therefore, an additional objective of the present study should be the
verification of inactivation and depletion procedures already in use for fixation,
inactivation and removal of infected cells or viruses. These procedures should be
assessed concerning subsequent utilisability of treated materials in research assays
outside biosafety level 3 containment laboratory.
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2 Materials and Methods
2.1 Cell culture
2.1.1 HUVEC
Human umbilical vein endothelial cells (HUVEC) were prepared by a method
described previously [Jaffe, 73] and modified recently [Thornton, 83].
Cultures of HUVEC were grown on gelatin-coated plates. Confluent cells in the
second passage were used for experiments. HUVEC were maintained in MCDB131
(Gibco BRL, Karlsruhe, Germany) supplemented with 5% fetal calf serum (FCS), 100
IU/ml penicillin, 100 µg/ml streptomycin, 1 µg/ml amphotericin B, 4.5 mM L-glutamine
and 20 µg/ml endothelial cell growth factor (ECGF).
2.1.2 Vero E6
Vero E6 (Vero C 1008, CRL 1586, ATCC) cells, african green monkey kidney
cells, were maintained in Dulbecco’s modified Eagle’s medium supplemented with
10% FCS, 100 IU penicillin, 100 µg/ml streptomycin and 4.5 mM L-glutamine.
Medium and FCS were certified endotoxin-free by the manufacturer’s.
2.1.3 Peripheral blood mononuclear cells and dendritic cells
Peripheral blood mononuclear cells (PBMC) were isolated by centrifugation
over Ficoll-Paque (Amersham Pharmacia Biotech, Germany) using buffy coats that
were supplied by the German Red Cross, Berlin. In a further step, monocytes were
separated from PBMC by adhesion to plastic for 1 h at 37°C, with contaminating cells
being removed by four washing steps. More than 75% of the resultant cells
expressed the CD14 markers. Immature dendritic cells were generated from
adhesion-purified monocytes by growth for 6 days in RPMI 1640 with with 10% FCS,
100 IU/ml penicillin, 100 µg/ml streptomycin, and 4.5 mM L-glutamine and
supplemented with 800 U/ml of both granulocyte-macrophage-colony-stimulating
factor (GM-CSF) and interleukin (IL) -4. Where required, mature dendritic cells were
generated from these cells by incubation with 1,000 U/ml tumor necrosis factor α
(TNFα) in addition to GM-CSF and IL-4 for another two days.
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2.2 Working with the virus
Hantaviruses present a hazard to all laboratory workers engaged in their study,
and appropriate precautions have to be taken in order to prevent infection. These
include wearing protective clothing including, at the minimum, mask, closed footwear,
and gloves. The handling of the virus is carried out under a hood so designed that
the air flows away from the worker to the exhaust, and on the way passes through a
filter system. All cultures, stocks, and other regulated wastes have to be
decontaminated before disposal by an approved decontamination method, such as
autoclaving.
2.2.1 Virus growth and stock production
Stocks of HTNV, strain 76-118 [Lee, 78], and TULV, strain Moravia [Plyusnin,
95], were propagated on Vero E6 cells. Cells grown in a 75 cm2 cell culture flask
(Nunc, Wiesbaden, Germany) were inoculated with 0.4 ml of a preexisting virus stock
in a total volume of 15 ml cell culture medium and incubated for 12 days in a
humidified atmosphere at 37°C. The cell culture supernatant was harvested, another
5% FCS added (final concentration of 10%), aliquoted and stored at –80°C until
further use. Concentrated viral stocks were prepared by pelleting virus from
supernatant of infected cells at 130,000 g for 4 hours at 4°C. Virus pellets were
resuspended in Tris-HCl buffer pH 7.6 supplemented with 5% FCS and stored at -
80°C until further use. Virus stocks were free of mycoplasma contamination as tested
by PCR.
2.2.2 Titration of virus stock
For virus titration a focus assay was performed essentially as described by
Heider et al., 2001. Briefly, Vero E6 cells were seeded into six-well plates. When
confluent, cells were inoculated with 0.2 ml/well HTNV diluted in dilution medium
containing Hank’s balanced salt solution (HBSS, GibcoBRL, Karlsruhe, Germany)
supplemented with 2% HEPES (GibcoBRL), 2% FCS, 100 IU/ml penicillin and 100
µg/ml streptomycin (GibcoBRL). After virus adsorption for one hour at 37°C wells
were overlaid with 2.5 ml/well of a pre-warmed (42°C) 1:1 mixture of 1% LE agarose
(Cambrex, East Rutherford, NJ) and basal Eagle’s medium supplemented with 2.5%
HEPES, 10% FCS and antibiotics. Plates were incubated for 7 days in a humidified
atmosphere at 37°C. The overlay was then discarded, cells washed twice with PBS
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supplemented with 0.15% Tween-20 and finally fixed for 8 minutes with methanol.
After the methanol has been removed cells were allowed to dry and again washed
two times. To detect hantaviral antigens in HTNV-infected cells an anti-DOBV-
positive, HTNV-cross-reactive human serum, kindly provided by Morten Schütt,
Lübeck, and horseradish-peroxidase (HRP)-labelled anti-human immune globulin
(Dianova, Hamburg, Germany) were used. TULV antigens were determined by
incubating cells with a rabbit serum raised against E. coli-expressed N protein of
TULV, strain Malacky [Sibold, 99]. The immune reaction was detected by addition of
a chemiluminescence substrate (Super Signal Ultra, Pierce, IL) and documented
using a DIANA II-CCD camera with an integrated, software controlled filter system
(Raytest Isotopenmessgeräte, Straubenhardt, Germany).
2.2.3 Infection of cells
For infection, equal quantities of viable virus or UV-inactivated HTNV (mock-
infection) were allowed to adsorb to HUVEC for 1 hr at 37°C. UV-irradiation for 5
minutes completely inactivated HTNV corresponding to a reduction of the viral titer of
at least 6 log scales (data not shown). Subsequently, a proof of infection was
performed using a focus assay in which virions from the supernatant of infected cells
were identified as being infectious (see 2.2.2). Alternatively, viral antigen was
detected in lysates of infected cell using Western blot technique (see 2.4) or in
infected cells by indirect immunofluorescence assay (see 2.3.2).
2.2.4 Safety precautions
Preparation of HTNV-containing samples during chemical inactivation
procedures.
To evaluate the inactivation capacities of the fixation agents (methanol,
paraformaldehyde, acetone/methanol) used to treat HTNV-containing samples, first
washing solutions and cell lysates obtained after the fixation procedure (Figure 5)
were collected. These samples were analysed for remaining replication-competent
HTNV in a subsequent “infectivity” focus assay. Moreover, the use of detergent-
containing cell lysis buffer was tested for its efficiency to reduce viral infectivity in a
similar way.























Figure 5. Viral inactivation and depletion procedures.
Flowcharts of virus infection, subsequent fixation of infected cells and preparation of samples from
infected cells after the fixation procedure.
For the fixation procedure (Figure 5) cells were grown in six-well plates and
then infected with serial dilutions of HTNV (usually 10, 100, 1,000, and 10,000 fold in
dilution medium, otherwise as indicated; wells 1-4). As a negative control 200 µl of
dilution medium alone was added to the 5th well. The 6th well was left empty, leaving
space for a following positive control well on the plate of the subsequent “infectivity”
focus test.
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addition of secondary antibody
detection of foci of virus-infected
cells by video imaging
Figure 6. "Infectivity" focus assay.
Flowchart of the subsequent “infectivity” focus assay for detection of infectious particles in lysates and
first washing solutions of infected cells after fixation.
After seven days of incubation at 37°C and 5% CO2, the agarose overlay was
discarded by gently injecting 1 to 2 ml of PBS under the agarose layer, cells were
washed once with PBS and treated with the respective agent. Generally, cells were
incubated with 2 ml/well of absolute methanol for 8 minutes, 1% paraformaldehyde
for 20 minutes, or acetone/methanol (1:1) for 10 minutes.
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Cells were then allowed to dry and, finally, 200 µl/well of PBS (with 5% FCS)
were added and eventually collected as first washing solution. In case of untreated
samples cells were washed with PBS only (first washing solution). To avoid the loss
of any infectious HTNV and thereby retaining maximal viral titers in this control
titration, drying of cells was left out.
After treatment, cell lysates were obtained by freeze-thaw-lysis in order to avoid
loss of viral infectivity by denaturing agents and after addition of 5% FCS lysates
were eventually stored at –80°C (Figure 5). Alternatively, lysis buffer containing 50
mM Tris-HCl (pH 7.4), 0.25 mM EDTA, 1 mM PMSF and 1% NP40™ was used to
extract proteins from virus-infected cells. These lysates were ultracentrifugated at
130,000 × g and 4°C for 2 h. Pellets were resuspended in 500 µl 50 mM Tris-HCl (pH
7.6) with 5% FCS and stored at –80°C until further use.
Replication-competent HTNV was detected in the subsequent “infectivity” focus
assay (Figure 6). An internal positive HTNV control of defined titer was added on
each six-well-plate.
Physical procedures of virus inactivation and depletion.
For virus depletion by filtration centrifugal filter devices containing low protein-
binding Omega™ membranes with 300 kDa or 1,000 kDa cut-off were used
according to the manufacturer’s instruction (Pall Life Sciences, Dreieich, Germany).
Filtrates were supplemented with 5% FCS and stored at –80°C until further use in the
“infectivity” focus assay.
Alternatively, virus stock solution (0.5 ml) was transferred into a small petri dish
and placed directly on the work space of a UV Transilluminator equipped with 8-watt
tubes (Vilber Lourmat, Torcy, France). Inactivation of hantavirus stock was performed
by UV-irradiation for 1, 3 and 5 minutes at 312 nm.
2.3 Immunological methods
2.3.1 Flow cytometry
For surface immunofluorescence analysis by flow cytometry cells in suspension
were washed once with ice-cold washing solution (PBS with 1% heat-inactivated fetal
calf serum and 0.05% sodium azide) before being resuspended with the first antibody
in ice-cold blocking solution (PBS with 10% heat inactivated fetal calf serum and
0.2% sodium azide) for 1 hour. Cells were then washed twice in ice-cold washing
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solution and the staining procedure was repeated with fluorescein isothiocyanate
(FITC)-coupled goat anti-mouse secondary antibody. After the final staining step cells
were washed twice in ice-cold washing solution and resuspended in 2 ml PBS with
1% formaldehyde. Tubes were left at 4°C overnight before being centrifugated. The
cells were resuspended in 200 µl of PBS with 0.2% formaldehyde before being
measured.
Antibodies. The following antibodies were used for flow cytometry: anti-ICAM-1
(clone HA58) and anti-HLA-DR, DP, DQ (clone Tü39) were purchased from
PharMingen, Heidelberg, Germany, anti-HLA I (clone W6/32) was obtained from
Serotec, Oxford, UK, and anti-VCAM-1 (clone 1G11) was purchased from
Immunotech, Marseille, France. As a non-reactive antibody, i.e. a non-specific
binding control or isotype control, anti-CD1a (clone NA1/34) from Biozol, Eching,
Germany, was added. As secondary antibodies FITC-coupled goat anti-mouse and
FITC-coupled swine anti-rabbit serum (DAKO, Hamburg, Germany) were employed.
Analysis. A FACScalibur, a Fluorescence Activated Cell Sorter and analyser, from
Becton Dickinson, Heidelberg, was used to quantify expression levels of labelled
molecules on the surface of the cells. In general, expression levels of a certain
molecule were presented as mean fluorescence intensity (MFI) against the overall
number of cells. The provided Cell Quest software allowed analysis of the obtained
data.
2.3.2 Immunofluorescence assay
Method. Since F-actin is concentrated along the margains of endothelial cells
rhodamine-labelled-phalloidin was used to visualise interendothelial gap formation as
well as changes in cell morphology. To this end, cells were fixed in paraformaldehyde
and then permeabilized using 0.1% Triton X-100 for 5 min followed by three washing
steps with phosphate-buffered saline (PBS). Eventually, F-actin was directly stained
with phalloidin.
To prove a recent infection by immunocytochemistry hantavirus-infected cells
were transferred onto slides, incubated overnight at 37°C and then fixed with
acetone/methanol (1:1) at 4°C for 30 min. Slides were washed thrice in PBS and
incubated for 1 h at room temperature with the first antibody in blocking solution
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(PBS with 10% heat-inactivated species-specific serum). Cells were then washed
again thrice in PBS and subsequently stained with the secondary antibodies in
blocking solution. Finally, cells were washed, embedded in mounting medium and
slides were stored at 4°C before being analysed.
Accordingly, cell surface molecules were stained on infected cells, however,
without prior permeabilisation.
Antibodies. The following antibodies were used for immunocytochemistry: anti-ICAM-
1 (clone HA58) was purchased from PharMingen, Heidelberg, Germany, and anti-
NFκB (clone C-20) was obtained from Santa Cruz Biotechnology, California. For
detection of HTNV the monoclonal antibody 1C12 specific for the hantaviral N protein
[Lundkvist, 91; Lundkvist, 02] or a HTNV-crossreactive human serum derived from a
hantavirus (Dobrava)-infected patient was used. Expression of TULV antigens was
determined by incubating cells with a rabbit serum raised against E. coli-expressed N
protein of TULV, strain Malacky [Sibold, 99]. As secondary antibodies FITC-coupled
goat anti-mouse and FITC-coupled swine anti-rabbit serum (DAKO, Hamburg,
Germany) were employed. F-actin was stained with rhodamine-labelled-phalloidin
Alexa 488 (Molecular Probes, Eugene, OR).
Analysis. Slides were sealed and examined in an IMT-2 fluorescence microscope
(Olympus Optical, equipped with an Olympus OM-4 camera) with an Olympus 63×
objective.
2.3.3 ELISA
Quantification of type I IFN. Concentrations of IFN-α and IFN-β in supernatants
harvested from infected cells were quantified using a sandwich ELISA kit (R&D
systems, Wiesbaden, Germany) according to the manufacturer’s instructions. Briefly,
a microplate precoated with polyclonal antibodies specific for IFN-α or IFN-β,
respectively, was used. Standards and samples were pipetted into the wells and any
IFN present was bound by the respective immobilised antibodies. After any unbound
substances were washed away, an enzyme-linked polyclonal anti-IFN-α or anti-IFN-β
antibody was added to the wells. Unbound antibody-enzyme reagent was washed
away and a substrate solution was added to the wells. Absorbance was determined
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at 450 nm and intensity increased in proportion to the amount of IFN bound in the
initial step.
Quantification of cell surface adhesion molecules. Expression of adhesion molecules
on monolayers of human endothelial cells was determined with a cell-surface ELISA
technique [Krüll, 96]. Briefly, confluent HUVEC monolayers in 96-well flat-bottom
microtiter plates were washed and infected with HTNV or mock-infected. Finally, cells
were fixed with 4% paraformaldehyde. Human Ig was used to reduce nonspecific
binding, and primary antibodies were added for 30 min. Thereafter, the cells were
washed three times and exposed to a horseradish peroxidase-conjugated rabbit anti-
mouse Ig antibody for 30 min. Finally, cells were washed again, o-phenylenediamine
was added for 5 min and absorbance was determined at 492 nm.
Antibodies. The following antibodies were used for cell surface ELISA technique:
anti-ICAM-1 (clone HA58) was purchased from PharMingen, Heidelberg, Germany,
and E-selectin (clone H18/7) was obtained from Serva, Heidelberg, Germany.
2.3.4 TUNEL assay
Apoptosis of endothelial cells was visualised by immunohistochemical detection
of DNA strand breaks [Gavrieli, 92]. Terminal deoxynucleotidyl transferase-mediated
dUTP nick end labeling (TUNEL) technique was used to detect endothelial cell
apoptosis (Boehringer, Mannheim, Germany). Briefly, hantavirus-infected or mock-
infected endothelial cells cultured on chamber slides were fixed in freshly prepared
paraformaldehyde (4% in PBS, pH 7.4). After blocking of endogenous peroxidase,
cells were permeabilized, TUNEL reaction mixture was added, and peroxidase
substrate was used to visualise apoptotic nuclei. Slides mounted on glass coverslips
were analysed under light microscopy (Olympus Optical, equipped with an Olympus
OM-4 camera) and documented on Kodak TMY 400 film.
2.3.5 IFN bioassay
For quantification of IFN-activity a bioassay was conducted [Yousefi, 85]. For
this purpose supernatant from infected HUVEC were transferred to A549 indicator
cells (3 x 104/well). On the next day, cells were infected with encephalomyocarditis
virus (EMCV). After 26 to 30 h medium was removed. To quantify the cytopathic
effect, cells were fixed with 4% glutaraldehyde and stained with 1% crystal violet. The
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dye was solubilised in 33% acetic acid, and the optical density of the eluate was
measured at 570 nm in a Labsystem Multiscan MS ELISA reader. The amount of IFN
is given as international reference units per milliliter, using exogenously added
National Institutes of Health human IFN as a reference. Polyinosinic-polycytidylic acid
(poly I:C) obtained from Sigma, München, Germany, was used to stimulate
production of type I IFN in control cells.
2.4 Proteinchemistry
2.4.1 Lysates
Cell extracts were prepared by lysing cells in lysis buffer containing 10 mM Tris-
HCl (pH 7.4), 1 mM EDTA, 100 mM NaCl, 1 mM PMSF, 1% Triton X-100 (wt/vol),
and protease inhibitors (2 µg/ml leupeptin, µg/ml antipain, and 2 µg/ml pepstatin). Cell
lysates were briefly centrifuged to remove cell debris. Total protein concentrations
were determined according to the Bradford procedure [Bradford, 76], using the
reagent kit and manufacturer's protocol purchased from BioRad Laboratories,
Richmond, CA. The assay is based on the observation that the absorbance
maximum for an acidic solution of Coomassie Brilliant Blue G-250 shifts from 465 nm
to 595 nm when binding to protein occurs. Both hydrophobic and ionic interactions
stabilise the anionic form of the dye, causing a visible color change. Samples were
then resuspended in gel-loading buffer according to Laemmli and boiled for 5 min.
2.4.2 SDS-PAGE
Proteins in the mass range from 30 to 150 kDa were separated on 10%
polyacrylamide gels containing 0.1% sodium dodecyl sulfate (SDS) with 50 µg total
protein per lane and run at 120 V (Mini-Protean III, Bio Rad, München). All gels were
run with Rainbow molecular weight marker RPN 800 purchased from Amersham Life
Science, UK.
2.4.3 Western blot
Method. Following electrophoretic separation, proteins were electrotransferred onto
Immobilon-P transfer membranes (Millipore, Schwalbach, Germany) in blotting
buffer (25 mM Tris, 192 mM glycine, 20% methanol). Thereafter, blots were blocked
for 1 h at room temperature in high-salt Tris-buffered saline, consisting of 50 mM
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Tris-HCl (pH 8.0), 500 mM NaCl, 0.05% Tween 20 (wt/vol), and 5% skim milk
(wt/vol). Blots were incubated overnight at 4°C with specific primary antibodies. Blots
were then washed thrice with high-salt Tris-buffered saline, followed by incubation
with appropriate secondary antibodies for 1 h at room temperature. After final
washing steps, detection was performed by enhanced chemiluminescence (ECL;
Amersham Life Science, UK) or by visualisation of fluorescence-labelled secondary
antibodies.
Antibodies. The following antibodies were used for Western blot analysis: anti-β-actin
antibody (ab 6276) was purchased from Abcam ltd., UK and anti-MxA monoclonal
antibody M143 was kindly provided by Otto Haller, Freiburg, Germany [Flohr, 99].
anti-IκB-α (clone C-21) and AKT (Ser 473) were obtained from Santa Cruz
Biotechnology, California, and anti-bcl-2 (clone 7) was purchased from BD
Biosciences, Heidelberg. Antibody 1C12 specific for hantavirus N protein was kindly
provided by Åke Lundkvist, Stockholm, Sweden.
For the proof of infection HTNV-crossreactive human serum derived from a
hantavirus (Dobrava)-infected patient was used. Expression of TULV antigens was
determined by incubating cells with a rabbit serum raised against E. coli-expressed N
protein of TULV, strain Malacky [Sibold, 99].
MAP kinases p38 and p42/44 as well as phospho-specific p42/44 (Tyr 204) and
phospho-specific p38 (Tyr 182) were purchased from New England Biolabs, Beverly,
MA. STAT-1 and phospho-specific STAT-1 (Tyr 701) were obtained from Biosource,
California.
Peroxidase-conjugated rabbit anti-mouse IgG (Amersham Pharmacia Biotech,
Dreieich, Germany) and IRDye 800- or Cy5.5-labelled secondary antibodies
(Odyssey infrared imaging system; LI-COR, Lincoln, NE) were used as appropriate.
2.5 Molecular biology
2.5.1 Real-time PCR
To quantify levels of mRNA of molecules of interest in hantavirus-infected or
mock-infected cells real-time PCR was conducted. This was kindly performed by
Thomas Giese in Heidelberg.
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RNA sample preparation. Cells (106) were lysed with 300 µl of MagnaPure lysis buffer
(Roche Applied Science, Mannheim, Germany) and samples were frozen at –80°C.
After thawing, lysates were mixed and transferred into MagnaPure sample cartridges
and mRNA was isolated with a MagnaPure-LC device using a standard protocol. The
elution volume was set to 50 µl. One aliquot of 8.2 µl RNA was reversely transcribed
using AMV-RT and oligo-(dT) as primer (first strand cDNA synthesis kit for RT-PCR,
Roche Applied Science) according to the manufacturer’s protocol in a thermocycler.
After termination of cDNA synthesis, the reaction mix was diluted to a final
volume of 500 µl and stored at –20°C until PCR analysis.
LightCycler PCR. Target sequences were amplified using LightCycler Primer Sets
(Search-LC, Heidelberg, Germany) with the LightCycler FastStart DNA Sybr Green I
Kit (Roche Diagnostics) according to the manufacturer’s protocol. RNA input was
normalised by the average expression of the housekeeping genes encoding β-actin
and cyclophilin B. Copy numbers were calculated from a virtual standard curve,
obtained by plotting a known input concentration of a plasmid to the PCR-cycle
number (CP) at which the detected fluorescence intensity reached a fixed value. The
data of two independent analyses for each sample and parameter were averaged
and presented as adjusted transcripts/µl cDNA or as ratios to control values.
2.6 Statistical methods and formula
The paired students t-test was used to analyse inter-group differences. A value
of P<0.05 was considered significant. The % inhibition of HLA class I-enhancement
on HUVEC by anti-IFN-β antibodies in Figure 32 was calculated on the basis of the





The major route of transmission of wildtype-hantaviruses to humans is via
aerosolised excreta from persistently infected rodent reservoir hosts. Therefore,
certain groups of people are at high risk for hantavirus infections due to their
residence and profession like farmers, rodent trappers, mammalogists and soldiers in
the field. Our infection studies clearly demonstrated the capacity of cell-culture
adapted hantaviruses to readily infect and replicate in human endothelial cells.
Therefore, experimental work on hantaviruses including infected tissues and viral cell
culture requires safety level 3 containment laboratories [CDC, 94].
In order to be able to use samples for subsequent cell biological, virological and
immunological investigations outside the safety level 3 containment laboratory
inactivation or depletion procedures for hantaviruses had to be established.
3.1.1 Hantaan virus is susceptible to a broad range of chemical inactivation
procedures.
Chemicals classically used for fixation of mammalian cells allowing subsequent
use of samples for different applications like IFA, cell surface ELISA, flow cytometry
analysis, immunoblot or focus assay were tested for their ability to inactivate HTNV.
To estimate the required incubation time and dosage of these agents needed to
completely inactivate HTNV the kinetics of inactivation were studied. The
experimental design for preparation of first washing solutions and cell lysates as well
as the subsequent analysing procedure are given in Figure 5 and 6.
Methanol fixation.
Methanol fixation for 8 minutes is classically used to fix cells for further use in
hantavirus focus test or focus reduction neutralisation assay, FRNT [Heider, 01].
The first washing solution after fixation and cell lysates obtained by freeze-thaw-
lysis were analysed separately. Fixation of HTNV-infected cells with methanol for 8
minutes depleted the number of focus forming units (FFU) in cell lysates completely,
i.e. by at least 7 log scales (Figure 7 b and Table 1). In line with this, all washing
solutions obtained from HTNV-infected and subsequently methanol-fixed cells did not
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show any remaining infectious HTNV (Figure 7 e and Table 1). These data were
confirmed both for washing solution and cell lysate in three independent experiments.
Paraformaldehyde fixation.
To prevent destruction of the cell surface for the analysis of outer membrane
proteins in a cell surface ELISA cells were treated with 1% paraformaldehyde for 20
minutes at room temperature. Cell lysates and first washing solutions were tested in
three and two independent experiments, respectively, for remaining infectious virus.
Figure 7. Inactivation of HTNV infectivity in lysates of infected cells and first washing
solutions after fixation.
Vero E6 cells were inoculated with HTNV (dilutions as indicated) or left uninfected (upper left well;
neg). Cell lysates obtained 7 days later without prior fixation (a) or after fixation with methanol for 8
minutes (b), paraformaldehyde for 20 minutes (c), and acetone/methanol for 10 minutes (d) were
tested for remaining infectivity in a focus assay on fresh Vero E6 cells. Simultaneously, the first
washing solutions after fixation of cells with methanol for 8 minutes (e) and paraformaldehyde for 20
minutes (f) were collected and screened for remaining infectivity in a focus assay on fresh Vero E6
cells. In all experiments an internal positive control with 200 FFU/well (lower left well; pos) was added.
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Lysates of HTNV-infected cells treated for 20 minutes with 1%
paraformaldehyde did not contain any remaining infectious virus (Figure 7 c).
Similarly, infectious virus could not be detected in washing solutions after 20 minutes
incubation with paraformaldehyde (Figure 7 f). Accordingly, incubation with
paraformaldehyde for at least 20 minutes reduced the titer of HTNV below the
detection limit, i.e. by at least 6 log scales (Table 1).
Acetone/methanol fixation.
In general, virus-infected cells transferred onto slides for an IFA are fixed by
incubation in acetone/methanol (1:1) for 10 minutes. In two independent experiments
the effectiveness of the fixation procedure was verified for HTNV-infected cells.
Remaining infectivity of cell lysates was determined by inoculation of the solution
onto fresh cells and subsequent "infectivity" focus assay. Titration of non-treated cells
revealed a titer of almost original infectivity (data not shown). After fixation with
acetone/methanol for 10 minutes infectious particles could not be detected in cell
lysates any longer, implying a reduction in virus titer of at least 6 log scales (Figure 7
d and Table 1).
Detergent-containing lysis buffer.
For use in Western blot analysis samples are usually boiled in a detergent-
containing lysis buffer. As the remaining denaturing substances would interfere with
the following titration of potentially preserved infectious particles on Vero E6 cells, an
ultracentrifugation step is needed to remove residual detergents. To test whether the
lysis buffer efficiently inactivates virus-infected cells, the appropriate lysates were
ultracentrifugated and pellets were used for subsequent analysis.
Titration of pelleted, non-treated freeze-and-thaw-lysates (without the use of
detergents) resuspended in a low-salt buffer, already showed a reduced amount of
foci compared to the number of input-virions (data not shown). This reduction of
infectivity can be attributed to the relatively harsh procedure of cell lysis prior to
ultracentrifugation. The use of lysis buffer containing a detergent led to complete
inactivation of infectious particles in the lysates, i.e. a reduction of the viral titer below
detection limits (at least 3 log scales) (Figure 8 b and Table 1).
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Figure 8. Inactivation of HTNV infectivity in infected cells by incubation with detergent-
containing lysis buffer.
Vero E6 cells were infected with HTNV (dilutions as indicated) or left uninfected (upper left well; neg)
and proteins were extracted 7 days later by detergent-containing lysis buffer (b). For comparison, an
untreated virus stock was titrated on an additional plate (a). Remaining infectious particles were
detected in a focus assay on fresh Vero E6 cells. An internal positive control (lower left well; pos) was
added.
Taken together, the results presented demonstrate the efficient inactivation of
HTNV by the chemical fixation procedures using methanol, paraformaldehyde,
acetone/methanol or detergent-containing lysis buffer. The obtained samples can
then be successfully subjected to various cell biological, virological and
immunological investigations.
3.1.2 Infectivity of Hantaan virus can be efficiently cleared by physical forces.
UV-irradiation.
To distinguish between intracellular changes caused by replication of a virus
and those only caused by adsorption and penetration without viral gene expression,
inactivation of viruses by UV-irradiation has been widely used. Inactivation of HTNV
stock was performed by UV-irradiation for 1, 3 and 5 minutes. Subsequently, the UV-
irradiated HTNV stock and a non-treated aliquot of the same stock (Figure 9 a) were









Figure 9. Dose-dependency of UV-irradiation mediated inactivation of HTNV.
HTNV stock solutions were left untreated (a) or were UV-irradiated for 1 min (b) and 3 min (c). Stock
solutions were diluted (as indicated) and then screened for remaining infectivity in a focus assay on
fresh Vero E6 cells. An internal negative control (upper left well; neg) contained only cell culture
medium. An internal positive control (lower left well; pos) was added.
Whereas UV-irradiation for only one minute leaves remaining infectious virus
(Figure 9 b), UV-irradiation for 3 minutes completely inactivated (Figure 9 c and
Table 1).
Virus Filtration.
The analysis of substances, such as cytokines, secreted by infected cells into
the supernatant requires the complete removal of infectious particles from the
solution, preferably without affecting the biochemical properties of those molecules of
interest. In this case, UV-irradiation or inactivation by chemicals might not be
suitable. Therefore, filters with low protein-binding Omega™ membranes with 300 or

















Figure 10. Detection of remaining infectivity of HTNV in supernatants of infected cells
after filtration.
Supernatants of cells infected with HTNV for 7 days or left uninfected (upper left well; neg) were
filtrated as described. Resulting filtrates from the use of membranes with a cut-off of 300 kDa (b) or
1,000 kDa (c) were diluted (as indicated) and screened for remaining infectivity in a focus assay on
fresh Vero E6 cells. An internal positive control (lower left well; pos) was added. For comparison, an
untreated virus stock was parallely titrated on an additional 6-well cell culture plate (a).
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While non-filtrated supernatants of infected cells contained about 1.5×105
FFU/ml three days after infection (Figure 10 a), filtration with a 300 kDa cut-off
membrane completely removed infectivity from the supernatant of infected cells
(Figure 10 b). However, filtrating supernatants of infected cells with a 1,000 kDa cut-
off membrane did not reduce the number of infectious particles (Figure 10 c).
In conclusion, physical forces such as UV-irradiation or virus filtration are
appropriate means to clear HTNV-infectivity. Suchlike treated supernatants or cell
lysates can be utilised in subsequent cell biological, virological and immunological
investigations as has been shown during our studies.
3.2 HUVEC as an in vitro infection model for hantaviruses.
Since the pathogenesis of HFRS is characterised by vascular instability and
viral antigen has in fact been found in endothelial cells of postmortem tissues from
patients with HFRS, human umbilical vein derived primary endothelial cells (HUVEC)
were chosen for the present infection studies [Peters, 99; Poljak, 94].
Although experimental infection of endothelial cells with hantaviruses has been
reported previously [Pensiero, 92; Yanagihara, 90], the susceptibility of the primary
endothelial cells to infection with the defined hantavirus strains used in this study was
verified. To this end, HUVEC were infected with pathogenic HTNV and
nonpathogenic TULV at different multiplicities of infection (MOI) and incubated over a
period of up to 7 days. Cells were examined for the presence of viral antigen, both by
IFA or by Western blot analysis.
3.2.1 Hantaviruses infected HUVEC in vitro without causing any apparent
damage to the cells.
Intracytoplasmic, virus-specific granular fluorescence was readily detectable in
endothelial cells 24 hours after inoculation with both hantaviruses tested, even when
infected at a low MOI of 0.1 (data not shown). However, infection with higher MOI
such as 1 or even 10 did not result in a drastically different effect. After three days of
infection nearly all cells of the monolayer cultures contained virus antigen,
independent of the amount of input-virus (Figure 11 a, d). The majority of the N
protein in the infected cells was localised in the perinuclear region. This distinctive
site of intracellular localisation of hantavirus antigen was observed for both HTNV
and TULV-infected HUVEC. Typically, cells exhibited a filamentous staining pattern
of the antigen during the first days of infection, while a punctuate pattern dominated
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the staining at later time points postinfection (Figure 11 b, e). In contrast, viral antigen
was not detected in uninfected HUVEC, which were included in the analysis as a













Figure 11. Detection of viral N antigen in HTNV- and TULV-infected HUVEC.
Cells were infected with HTNV or TULV at a MOI of 1. Three days postinfection the distribution of viral
antigen was visualised by immunocytochemistry in TULV-infected HUVEC by using a rabbit-derived
polyclonal antiserum (d) and in HTNV-infected HUVEC by employing monoclonal antibody 1C12
specific for hantavirus N protein (a). Original magnifications, ×63. After six days of infection staining of
TULV antigen (e) and HTNV antigen (b) was dominated by a punctuate pattern. Original
magnifications, ×63 and ×40, respectively. As a negative control uninfected HUVEC were included in
the analysis (c, f). Original magnifications, ×40.
Likewise, viral N antigen could be detected by Western blot analysis as early as
24 hours postinfection in cells infected at both MOI 0.1 or 1, again using HTNV-
crossreactive human antiserum or a mouse-derived monoclonal antibody (Figure 12).
As expected, hantavirus antigen was undetectable in mock infected HUVEC using
UV-irradiated viruses (Figure 12).
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Figure 12. Expression of viral N antigen in HUVEC infected with HTNV or TULV.
HUVEC were infected with HTNV, TULV or UV-inactivated virus (mock infection) at MOI of 1. Lysates
were prepared at different time points postinfection. Expression of viral antigen was analysed by
Western blotting using human-derived antiserum or monoclonal antibody 1C12. Lysates of VeroE6
cells incubated for 5 days with HTNV were used as a positive control. The results shown are
representative of three independent experiments with HUVEC derived from three different donors.
These results show that human endothelial cells readily support HTNV- and
TULV-antigen production in vitro. On the basis of the morphological characteristics of
viable endothelial cells cytopathic effects could never be observed by light
microscopy analysis at any time point postinfection (Figure 13).
cba
Figure 13. Staining of cytoskeletal structures in HUVEC infected with HTNV.
Staining of confluent cultures of human umbilical vein endothelial cells (HUVEC) with rhodamine-
labelled phalloidin which specifically labels actin filaments, but not actin monomers. Organisation of
actin microfilaments is essential for the shape of an endothelial cell (a). Stimulation with TNFα was
associated with a characteristic loss of the peripheral actin band and increased intensity of actin stress
fibers throughout the cell (c). Infection with HTNV (MOI 1) did not result in altered cytoskeletal
structures (b).
3.2.2 Modulation of molecules involved in apoptosis was not observed in
hantavirus-infected HUVEC.
The earliest indications of apoptotic cell death are morphological alterations of
cells such as chromatin condensation, disappearance of the nucleolus, and
alterations of the cell surface, characterised by the occurrence of blebs [Huppertz,
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99]. However, such indices of apoptosis have never been observed in hantavirus-
infected primary cells in vitro.
a b c
Figure 14. Apoptosis was not detected in HTNV-infected cells.
HUVEC were grown in chamber slides and infected with HTNV (MOI 1) when being confluent. At
different time points postinfection DNA strand breaks were detected in situ using the TUNEL assay
[Gavrieli, 92]. Stimulation with staurosporin induced apoptosis in HUVEC manifested as green
fluorescence signals in the nucleus (a). In untreated control cells (b) as well as in HTNV-infected cells
(day 3 postinfection, c) apoptosis could not be detected.
Extensive DNA degradation is a characteristic event which occurs in the early
stages of apoptosis. DNA strand breaks can be detected in a TUNEL assay by
enzymatic labelling of the free 3'-OH termini with modified nucleotids such as FITC-
dUTP. Apoptotic cell death can then be visualised by fluorescence microscopy. To
this end, HUVEC were infected with HTNV at a MOI of 1 and subjected to a TUNEL
assay three and five days postinfection. Whereas stimulation of HUVEC with
staurosporin for six hours strongly induced DNA strand breaking (Figure 14 a),
infection with HTNV did not result in detectable levels of DNA strand breaks pointing
to apoptotic cell death (Figure 14 c), nor did it in untreated control cells (Figure 14 b).
Apoptotic cell death is an active process which requires controlled gene
expression. The failure of hantaviruses to induce apoptosis might be the result of
specific induction of anti-apoptotic molecules such as protein kinase Akt or bcl-2.
To address the question whether hantaviruses are capable to interfere with
apoptosis and thereby promote cell survival, HUVEC were infected with pathogenic
HTNV at MOI of 0.1. Cell lysates were extracted at different time points postinfection
and expression levels of bcl-2 protein were determined by immunoblot analysis.
HTNV-infected HUVEC did not show induction of bcl-2 protein at any time point
analysed from 30 minutes up to 24 hours postinfection (data not shown), and TNFα
failed to induce expression of bcl-2. Furthermore, cells infected with HTNV in the
same timeframe were treated with TNFα for 30 minutes prior to cell lysis to evaluate
the ability of the virus to intercept a strong apoptotic stimulus. However, a modulation
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of expression levels of bcl-2 could not be detected in endothelial cells, that had been
both infected with HTNV and stimulated with TNFα. Again, neither in uninfected
control cells nor in TNFα treated endothelial cells, used as positive control, altered
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Figure 15. Expression level and activation status of proteins involved in apoptosis in
response to a hantavirus infection.
(A) Cell lysates prepared after infection with HTNV (MOI 0.1) or after HTNV infection with subsequent
TNFα-treatment were subjected to Western blot analysis. Expression levels of bcl-2 protein were
determined at different time points postinfection using a specific bcl-2 antibody. (B) Additionally, cells
were infected with HTNV or TULV (MOI 1) and proteins were extracted at different time points
postinfection. Amounts of phosphorylated protein kinase Akt were determined by Western blot
analysis using protein kinase Akt phosphospecific antibody. The results presented are representative
of three independent experiments with cells derived from three different donors.
To assess the relevance of the protein kinase Akt in the context of apoptosis
due to an infection with hantaviruses, HUVEC were infected with both pathogenic
HTNV and nonpathogenic TULV at a MOI of 1. Again, proteins of infected cells were
extraced by cell lysis at different time points postinfection. Activation, i.e.
phosphorylation, of protein kinase Akt in response to an infection with hantaviruses
was analysed by immunoblot using phospho-Akt-specific antibodies.
Levels of phosphorylated protein kinase Akt were low in uninfected or mock-
infected control cells and stimulation with TNFα or IFN-β did not result in a distinct
increase of activated Akt. TULV-infection did not lead to altered amounts of
phosphorylated Akt in HUVEC at any time point analysed from 1 hour to three days
postinfection (data not shown). Similar results were obtained for HUVEC infected
with HTNV. However, after 24 hours of infection with HTNV a distinct but transient
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increase of phosphorylated protein kinase Akt was detected in lysates of infected
HUVEC (Figure 15 B). In contrast, HUVEC infected with HTNV for two or three days
did not show elevated amounts of phospho-Akt (Figure 15 B and data not shown).
In conclusion, these experiments could not demonstrate a significant impact of
programmed cell death in primary endothelial cells in the course of an infection with
both pathogenic HTNV or nonpathogenic TULV. Both anti-apoptotic bcl-2 and protein
kinase Akt were not induced in response to an infection with HTNV or TULV, except
for a short however transient activation of protein kinase Akt after 24 h of HTNV
infection. Furthermore, DNA fragmentation which would directly point to apoptosis
could not be observed in HTNV-infected HUVEC.
3.2.3 Kinetics of a productive infection with hantaviruses varied between
HTNV and TULV.
The presence of virus antigen in infected cells, however, does not tell us
whether the virus is actually multiplying. To adress this question, medium was
removed from hantavirus-infected HUVEC at different time points after infection. For
comparison, Vero E6 cells, lacking type-1 IFN genes [Diaz, 88], were likewise
infected with HTNV or TULV. The production and subsequent secretion of infectious
virus progeny into the supernatant was determined by focus assay.
HUVEC showed production of HTNV and TULV on day one postinfection, when
infected at MOI of 1. The viral titers peaked about one to three days after inoculation
with the respective virus and then declined over the next days (Figure 16). However,
it was observed that cells infected with the nonpathogenic TULV produced much
fewer viral particles than HTNV-infected HUVEC. Two days postinfection, for
instance, viral titers produced by HTNV-infected cells added up to 106 focus-forming
units (FFU)/ml. In the supernatant of TULV-infected HUVEC, however, only 103
FFU/ml were detected. Endothelial cells did not produce significant levels of
infectious HTNV after six to seven days of infection, whereas the level of TULV
production ceased even earlier.
These results indicate that both the pathogenic HTNV and the nonpathogenic
TULV could not only successfully enter HUVEC and induce viral antigen production,
but were also able to efficiently replicate within these cells. However, yields of
infectious HTNV were somewhat higher in HUVEC compared to TULV which
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replicated far less efficiently. In fact, HTNV but not TULV creates a time window from


















































Figure 16. Kinetics of virus production in HTNV- or TULV-infected cells.
Supernatants of infected cells were collected at the time points indicated and virus titers were
determined by chemiluminescence focus detection assay using human-derived anti-DOBV-positive,
HTNV-cross-reactive, or anti-PUUV-positive, TULV-cross-reactive sera, respectively. Kinetics of virus
production by HTNV-infected (A) and TULV-infected (B) HUVEC and VeroE6 cells are presented over
a period of seven days postinfection. HUVEC derived from three different donors were used in three
separate experiments. Vero E6 cells were used in two individual experiments. Titers obtained are
given as mean ± SD and are shown on log scale.
Until day 2 postinfection HTNV could replicate in HUVEC nearly as efficient as
in Vero E6 cells. Thereafter, viral titers produced by HTNV-infected HUVEC declined
whereas viral titers produced by HTNV-infected Vero E6 cells remained high. In
contrast, TULV-infected HUVEC produced only low viral titers showing no peak when
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compared to TULV-infected Vero E6 cells. Both hantavirus species can efficiently
grow in Vero E6 cells lacking type-1 IFN genes (Figure 16).
3.3 Intracellular responses to a hantavirus infection.
In the absence of observable cytopathology, hantavirus infection of endothelial
cells may result in altered gene regulation, such as an increased expression of
inflammation markers or antigen presentation molecules. Alternatively, a hantavirus
infection may provoke a modulation of the activation status of intracellular signal
transduction pathways. Such modulation may include phosphorylation of
constitutively expressed molecules which are then available in their active version.
3.3.1 HTNV infection failed to activate MAP kinases in HUVEC.
At the molecular level, such modulation of signal transduction pathways is often
achieved by activating or deactivating regulatory proteins through phosphorylation by
protein kinases. To begin with, focus was put upon the intracellular pathways
involved in inflammation such as the MAP kinase family. To assess whether the
mitogenic p38 and p42/44 kinase cascades are activated by hantaviruses, HUVEC
were infected with HTNV at different multiplicities of infection (MOI 0.1 and 1). Cells
were subsequently analysed for p38 and p42/44 activity at different time points after
infection.
In an intact endothelial cell both MAP kinases mentioned are constitutively
expressed, but are not activated. Generally, MAP kinase p38 becomes activated and
thereby phosphorylated by a variety of stress signals including UV irradiation,
inflammatory cytokines, and, intriguingly, dsRNA [Iordanov, 00]. In fact, activation of
MAP kinase p38 was regularly observed in HUVEC stimulated with 10 ng/ml TNFα
for 10 minutes. However, after infection with HTNV phospho-p38 MAP kinase-
specific bands could not be detected in Western blot analyses at any time point
postinfection. The time frame analysed ranged from 15 minutes to 30 hours after
inoculation with pathogenic HTNV (Figure 17). Even an infection with high viral doses
(MOI 10) did not lead to an activation of MAP kinase p38 (data not shown).
Similar results were obtained for MAP kinase p42/44 (data not shown).
Accordingly, activation of this proliferation and differentiation MAP kinase was not
observed in HUVEC at any time point postinfection, even when HUVEC were
infected at high MOI. The efficient infection of cells was randomly proven by



















Figure 17. Analysis of phosphorylated MAP kinase p38 in HUVEC after infection with
HTNV.
After infection with HTNV or TULV (data not shown) at MOI 1 cell lysates were extracted at different
time points ranging from 15 minutes to 30 hours postinfection. Phosphorylation of MAP kinase p38
was demonstrated by Western blot analysis using a p38 phosphospecific antibody and a Cy5.5–
labelled secondary antibody. TNFα treatment of cells served as positive control. Parallel staining of
the Western blot membrane using an anti-p38 antibody, which recognises all forms of p38, and a
IRDye 800–labelled secondary antibody, demonstrated that the overall levels of p38 as well as the
amount of loaded protein did not fluctuate. Separate experiments were conducted with cells derived
from three different donors. On the left side images are displayed in colour with both colour channels
overlaid, whereas greyscale images are separately shown on the right side.
These findings indicate that infection of endothelial cells with both pathogenic
HTNV or nonpathogenic TULV does not induce activation of the highly conserved
cytosolic serine/threonine protein kinases p38 or p42/44. Both hantaviruses evidently
do not belong to the stress factors known to activate signalling events involved in
inflammatory responses.
3.3.2 Analysis of potential NFκB activation and IκB-α degradation in HUVEC
after infection with hantavirus.
Since an inflammatory response to a hantavirus infection on the level of MAP
kinases could not be revealed, it seemed obvious, to analyse a more downstream
component of signalling pathways involved in inflammation.
Activation of the transcription factor NFκB has been reported to occur rapidly in
response to an extremely wide range of stimuli, including cytokines, physical stress
or viral proteins. Two different approaches are applicable to examine the activation of
NFκB: its translocation into the nucleus on the one hand, and the degradation of its
inhibitor IκB-α on the other hand. This inhibitor is a primary target of signalling
pathways which are activated by inflammatory stimuli, and which eventually result in
its phosphorylation and subsequent proteolytic degradation. Once released from its
inhibitor NFκB readily translocates into the nucleus.
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Hantavirus infection did not cause translocation of NFκB into the nucleus.
We used a polyclonal anti-NFκB antibody and fluorescence microscopy to
evaluate NFκB activity in HUVEC. Strong fluorescent signals were observed in the
cytoplasm of untreated endothelial cells (Figure 18 a). After treatment with 100 ng/ml
TNFα for 15 minutes cytoplasmic fluorescence decreased while nuclear fluorescence
increased (Figure 18 c). This clearly demonstrated the translocation of activated
NFκB protein from the cytoplasm into the nucleus in response to this proinflammatory
cytokine. However, an infection with HTNV at a MOI of 0.1 did not lead to an
activation of NFκB at any time point analysed, ranging from 15 minutes to 48 hours
postinfection. Accordingly, fluorescence was predominantly detected in the
cytoplasm of infected HUVEC (Figure 18 b).
a cb
Figure 18. Cellular localisation of NFκB after an infection with HTNV.
Cells were infected with HTNV (MOI 0.1) and the cellular localisation of NFκB was visualised by
immunofluorescence microscopy using NFκB-specific antibody. TNFα induced rapid translocation of
NFκB p65 from the cytoplasm to the nucleus in HUVEC (c). NFκB nuclear localisation could not be
observed in untreated (a) or HTNV-infected cells (b).
Degradation of IκB-α could not be detected after infection with hantavirus.
The steady state level of cytoplasmic IκB-α protein was measured by Western
blot analysis, using a polyclonal anti-IκB-α antibody.
In cell extracts of untreated HUVEC consistent amounts of IκB-α could be
detected, whereas stimulation of HUVEC with 10 ng/ml TNFα lead to a rapid
proteolysis of IκB-α as virtually all the IκB-α present in the cytoplasm was degraded
within 15 minutes. Infection with both pathogenic HTNV or nonpathogenic TULV at
MOI of 1 did not lead to a change in the amount of IκB-α detected in the cell extracts
at any time point analysed (Figure 19 A).
However, a viral infection might have as well an impact upon the cellular
reaction to a stimulation with TNFα. A stabilisation of complexed IκB-α by the virus
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could, for instance, suppress or postpone inflammatory processes in response to the
viral infection. To adress this question, HUVEC were infected with HTNV (MOI 1) and
subsequently stimulated with 10 ng/ml TNFα.
Treatment of HTNV-infected cells with TNFα, though, led to the usual
degradation of cytoplasmic IκB-α. No difference between infected or uninfected cells








































Figure 19. Degradation of cytoplasmic IκB-α after HTNV or TULV infection.
(A) After infection of HUVEC with HTNV or TULV (MOI 1) cell lysates were prepared at different time
points ranging from 10 min to 30 h postinfection. For negative control cells were left uninfected.
Treatment with TNFα was used as a positive control. (B) Additionally, cells were infected with HTNV
and subsequently treated with TNFα. By Western blot analysis using IκB-α antibody levels of
cytoplasmic IκB-α were detected. 50 µg of cytoplasmic protein were loaded on all lanes. Cells derived
from three different donors were subjected to Western blot analyses in three independent experiments
and representative results are presented.
Thus, infection with pathogenic HTNV as well as nonpathogenic TULV does not
lead to activation of central transcription factor NFκB. Likewise, a modulation of its
inhibitor IκB-α could not be observed after infection.
3.4 Modulation of immunoregulatory proteins after a hantavirus infection.
Innate immunity represents the first line of cellular defence against invading
pathogens, including viruses, before a complex adaptive immune response is
launched against such pathogens. One of the principal features of innate immunity is
activation of the already mentioned NFκB transcription factor. Genes activated by
NFκB play an important role in both adaptive (cytokines, adhesion molecules and
HLA class I molecules) and innate (cytokines such as IFN) immune response.
Although activation of NFκB was not observed in the prior experiments,
modulation of molecules involved in both the innate as well as in the adaptive
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immune response, namely adhesion molecules, antigen presentation molecules and
IFN, was investigated. A weak induction of this central transcription factor might have
been overlooked or, alternatively, NFκB-independent gene transcription might have
occurred.
3.4.1 Hantaviruses slightly upregulated levels of adhesion molecules.
Cell adhesion molecules are central factors for leukocyte adherence and the
propagation of inflammatory responses. In fact, recognition of and adhesion between
T lymphocytes and infected target cells can be enhanced by ICAM-1 and VCAM-1.
To compare such cellular responses endothelial cells were infected at a MOI of
1 by pathogenic HTNV or nonpathogenic TULV. Expression levels of these cell
surface molecules were then visualised by flow cytometry analysis at different time
points postinfection (Figure 20).
A slight though consistent increase in levels of ICAM-1 was observed on the
surface of HUVEC infected with pathogenic HTNV or nonpathogenic TULV over six
days (Figure 20 B), whereas such an upregulation could not be detected for VCAM-1
(data not shown). The effect was not observed after mock-infection of HUVEC with
UV-inactivated hantaviruses. Uninfected HUVEC treated with 10 ng/ml TNFα for 24
hours, however, exhibited a strong upregulation of both ICAM-1 and VCAM-1 three
days after stimulation (data not shown).
Taken together, these results do not reveal overall distinctly increased
expression levels of cell adhesion molecules VCAM-1 or ICAM-1 in response to an
infection with hantaviruses HTNV or TULV. Moreover, cell surface ELISA technique
could not demonstrate an induction of adhesion molecules such as ICAM-1 or E-




































Figure 20. Expression levels of ICAM-1 on HUVEC after infection with HTNV or TULV.
HUVEC were infected with HTNV or TULV (MOI 1). Infection with UV-irradiated HTNV was included
as mock-infection. Expression levels of ICAM-1 were evaluated by flow cytometry analysis. (A)
Unfilled curves show staining of cells with an isotype control antibody, whereas grey filled-in curves
represent expression of ICAM-1 at day three postinfection. Mean fluorescence intensity (MFI) values
given in the upper right corner of each histogram are representative for three separate experiments
with cells derived from three different donors. (B) Temporal pattern of ICAM-1 expression on HTNV- or
TULV-infected HUVEC. The y-axis shows the MFI at day 1 to 6 postinfection as indicated. One
representative experiment out of five is depicted.
3.4.2 Hantaviruses modulated antigen presentation molecules.
Apart from the above-mentioned cell adhesion molecules, additional molecules
on the surface of infected cells are important for the functioning of antiviral T
lymphocytes.
In fact, both CD4- and CD8-positive T lymphocytes have to interact with antigen
presenting molecules in order to gain functional activity and to monitor infection.
Recognition of antigen-presenting molecules, namely HLA class I, on the surface of
an infected cell by cytotoxic CD8-positive T lymphocytes will eventually result in the
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elimination of such virus-infected cells. Activation of helper CD4-positive T
lymphocytes relies on the interaction with HLA class II molecules to support the
elimination of virus-infected cells. HLA class II molecules are usually not expressed
on endothelial cells. However, IFN-γ is able to induce such unusual expression
pattern and thereby promotes the recognition of infected cells by helper T
lymphocytes.
Neither HTNV- nor TULV-infected HUVEC expressed HLA class II molecules at
any time point analysed. In contrast, HUVEC treated with IFN-γ showed clearly




















Figure 21. HLA class II-expression on HUVEC in response to an infection with HTNV or
TULV.
Cells were infected with HTNV or TULV (MOI 1) and stained for HLA class II molecules three days
after infection. Mock-infected cells were included as a control. Stimulation with IFN-γ induces the
upregulation of HLA class II in endothelial cells and served as positive control. In order to detect
synergistic effects infected cells were simultaneously stimulated with IFN-γ as indicated. Expression
levels of HLA class II molecules were quantified by flow cytometry. Mean fluorescence intensity values
(MFI) are given as mean ± SD of three individual experiments with cells derived from three different
donors.
Both HTNV and TULV strongly augmented the expression of HLA class I
molecules on the surface of HUVEC at day 3 postinfection (Figure 22 A). Kinetic
analyses revealed that TULV-infected HUVEC more rapidly upregulated HLA class I
molecules with a peak at day 2 to 3 postinfection. In contrast, HTNV-infected HUVEC
more gradually increased expression of HLA class I molecules reaching peak levels
at day 4 to 5 postinfection. These phenotypic changes were not observed after mock-
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Figure 22. Temporal pattern of HLA class I expression on HTNV- or TULV-infected
HUVEC.
HUVEC were infected  with HTNV or TULV (MOI 1). UV-irradiated HTNV was used for mock-infection.
(A) Histograms are showing HLA class I expression at day 3 postinfection as indicated. As a positive
control HUVEC were treated with IFN-β (20 000 U/ml for 24 h). Grey filled-in curves represent
expression of HLA class I molecules, whereas unfilled curves show staining of cells with an isotope
control antibody. On the x-axis, the fluorescence intensity (log scale, 4 decades) is shown, the y-axis
depicts the relative cell number. Mean fluorescence intensity (MFI) values are depicted in the upper
right corner of each histogram. The results shown are representative of eight separate experiments
with cells derived from eight different donors. (B) The kinetics of HLA class I expression on HTNV- and
TULV-infected HUVEC were analysed. The y-axis shows the MFI at day 1 to 5 postinfection as
indicated. One representative experiment out of eight is depicted.
An infection with a low virus dose such as MOI of 0.1 did not result in increased
expression levels of HLA class I molecules on the surface of HUVEC. However,
augmented expression levels of HLA class I molecules could be detected
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reproducibly after infection with hantavirus at MOI of 1 or 10 (Figure 23). Apparently,
the MOI used has a strong impact upon the results obtained in the studies described
here. Conclusions drawn from infection experiments using a low MOI of 0.1 do not
necessarily hold true for experiments conducted at higher MOI such as 1 or even 10.






















Figure 23. Influence of viral load on expression levels of HLA class I molecules on
endothelial cells.
HUVEC were left uninfected or infected with HTNV at different MOI (0.1, 1 or 10). At day 3
postinfection expression levels of HLA class I molecules were determined by flow cytometry analysis.
Grey filled-in curves represent expression levels of HLA class I molecules whereas unfilled curves
show staining of cells with an isotope control antibody. On the x-axis, the fluorescence intensity (log
scale, 4 decades) is shown. The y-axis depicts the relative cell number. The mean fluorescence
intensity (MFI) is given in the upper right corner of each histogram. The results shown are
representative of three separate experiments with cells derived from three different donors.
3.4.3 Production of IFN was adjusted by hantaviruses.
The innate immune response, including the production of cytokines, represents
a hallmark of the host defence against viral infections. The antiviral cytokine IFN-α/β
(type I IFN), produced following viral infection, exerts an antiviral state by inducing
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the Janus kinases/signal transducer and activator (JAK-STAT) pathway. IFN-γ (type
II IFN) increases the efficiency with which target cells present viral antigen in
association with HLA class I molecules for recognition by cytotoxic T lymphocytes.
Moreover, IFN-γ induces the expression of HLA class II proteins on the surface of
cells that do not normally express them. Thereby such cells, like endothelial cells, are
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Figure 24. Production of IFN-β by endothelial cells after infection with HTNV or TULV.
ELISA technique was used to analyse supernatants from infected HUVEC (MOI 1) collected at the
time points indicated. As a positive control supernatant from cells treated with poly I:C (10 µg/ml for 24
h) was included. Supernatants from mock infected cells served as negative control (data not shown).
Concentrations (pg/ml) are given as mean ± SD of three individual experiments with cells derived from
three different donors.
To assess the role of type I and type II IFN during a hantavirus-infection their
synthesis was evaluated in HUVEC infected with pathogenic HTNV or nonpathogenic
TULV at a MOI of 1 at different time points postinfection.
As a positive control HUVEC were treated with poly I:C, a synthetic mimic of
double-stranded RNA. HUVEC treated with poly I:C for 24 hours released high
amounts of IFN-β whereas infected cells produced much less cytokine as determined
by ELISA technique. In the supernatant derived from HTNV-infected HUVEC
consistently higher amounts of IFN-β were found than in supernatant collected from
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cultures of TULV-infected HUVEC (Figure 24). Neither HTNV nor TULV induced
HUVEC to secrete IFN-α (data not shown).
Additionally, IFN production was assessed in a bioassay that measured antiviral
activity in the supernatant of infected cells. Again, an antiviral activity was detected in
supernatants of poly I:C treated control cells and HTNV-infected but was barely
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Figure 25. Detection of antivirally active IFN in the supernatant of hantavirus-infected
HUVEC.
A bioassay as described in materials and methods was employed to determine the concentration of
IFN-β in supernatants collected from infected HUVEC (MOI 1) at the time points indicated. Uninfected
cells served as a negative control. Stimulation with poly I:C strongly induces production of IFN and
was used as a positive control. Concentrations are given as mean ± SD of two independent
experiments with cells derived from two different donors.
Production of IFN type I molecules was also monitored on the mRNA level by
quantitative real-time RT-PCR technique. This type of analysis revealed that HTNV
increases the production of IFN-β mRNA postinfection starting at day 2, reaching
peak levels at day 4 and decreasing thereafter. In comparison, TULV-infected
HUVEC produced only low amounts of IFN-β transcripts whereas mock-infection
(UV-HTNV) had no effect (Figure 26). Neither HTNV- nor TULV-infected HUVEC
showed induction of IFN-α, IFN-γ or IFN-λ, a recently discovered type I IFN, gene
transcription (data not shown).
Taken together, these findings suggest that HTNV elicits a stronger IFN-β























Figure 26. Quantification of IFN-β transcripts in HUVEC in response to an infection
with HTNV or TULV.
Quantitative real-time RT-PCR analysis was performed to determine the relative copy number of IFN-β
transcripts in HUVEC in response to an infection with HTNV or TULV (MOI 1). As a positive control
cells were stimulated with poly I:C and subjected to the same analysis. UV-inactivated HTNV was
used for mock infection. RNA was isolated at the time points indicated. The results depicted are given
as mean ± SD and are derived from three individual experiments with cells from three different donors.
HTNV and TULV differentially regulated gene expression associated with IFN
type I production.
This differential antiviral response observed in HTNV- or TULV-infected HUVEC
was mirrored in the expression patterns of interferon regulatory factor-3 (IRF-3) and
interferon regulatory factor-7 (IRF-7), transcription factors involved in establishing an
innate antiviral state. IFN type I is induced in a virus-infected cell as a result of
activation of NF-κB or IRF-3 or both. IRF-7, induced by IFN-β, then triggers the
induction of different IFN genes (Figure 27).
Production of IRF-3 and IRF-7 was therefore measured in hantavirus-infected
HUVEC. Again, poly I:C treated endothelial cells were used as a positive control
showing increased levels of both IRF-3 and IRF-7 transcripts by quantitative real-time






























































Early events Delayed events
Figure 27. Early and delayed events in the IFN system.
In response to virus infection a number of signal transduction pathways are activated, ultimately
leading to the activation of transcription factors that regulate immediate early genes, among which are
the genes that encode type I IFN. Once secreted, IFN interact with a specific receptor at the surface of
surrounding cells to induce the JAK/STAT signalling pathway, resulting in the activation of the IFN-
stimulated gene (ISG) transcription factor (ISGF)-3, transcriptionfactor ATF-2/c-Jun, and the
production of interferon regulatory factor (IRF)-7. Upon virus infection, IRF-3, IRF-7 and CREB-binding
protein (CBP) contribute to the expression and amplification of the IFN response by inducing delayed
type I IFN genes and genes that result in an antiviral state. From:Grandvaux et al., 2002 (modified).
These findings demonstrate that pathogenic and nonpathogenic hantaviruses
are in fact different with regard to the virus-induced IFN response in endothelial cells.
HTNV induced synthesis of IFN-β which was barely detectable after an infection with
TULV. However, neither HTNV nor TULV induced significant levels of IFN-α or IFN-λ.
In HTNV-infected HUVEC strongly enhanced levels of IRF-3 and IRF-7 transcripts
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Figure 28. Transcription patterns of IFN response genes induced in HUVEC after
hantavirus infection.
RNA was isolated from HUVEC three days after infection with HTNV or TULV (MOI 1). Subsequently
real-time RT-PCR analysis was performed to measure transcript levels of IFN and interferon
regulatory factors (IRF)-3 and -7 as well as 2´-5´-oligoadenylate synthetase (OAS). Values are given
as percentage of the maximal expression levels induced by poly I:C which served as positive control
stimulus. UV-inactivated HTNV was used for mock infection (data not shown). The results depicted
are mean ± SD derived from three independent experiments with cells from three different donors.
These findings demonstrate that pathogenic and nonpathogenic hantaviruses
are in fact different with regard to the virus-induced IFN response in endothelial cells.
HTNV induced synthesis of IFN-β which was barely detectable after an infection with
TULV. However, neither HTNV nor TULV induced significant levels of IFN-α or IFN-λ.
In HTNV-infected HUVEC strongly enhanced levels of IRF-3 and IRF-7 transcripts
were detected. However, this upregulation was observed to a far lesser extent in
TULV-infected HUVEC.
3.4.4 Increased expression of IFN-inducible proteins was observed in
response to hantavirus infection.
IFN as antiviral and antiproliferative cytokines mediate their effects mainly
through well-conserved signalling pathways. Major molecular players involved in
transducing antiviral IFN signals, namely molecules of the signal transducer of
activation and transcription (STAT) family and MxA, were investigated.
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HTNV but not TULV induced upregulation of STAT-1.
IFN type I signalling is furthermore mediated by phosphorylation of STAT-1.
Such activated STAT molecules translocate into the nucleus and eventually activate
IFN-stimulated antiviral genes. Diverse protein kinases, including the already
mentioned MAP kinases, phosphorylate STATs and with it potentiate the primary
STAT-activating stimulus which induces phosphorylation and subsequent















































Figure 29. Production and activation status of STAT in HUVEC after infection with
hantaviruses.
(A) HUVEC were infected with HTNV or TULV (MOI 1). Three days after infection RNA was isolated
from cells and subjected to real-time RT-PCR analysis to quantify transcript levels of STAT-1.
Stimulation with poly I:C (10 µg/ml for 24 h) served as positive control. The results depicted are
relative copy numbers with mean ± SD derived from three independent experiments with cells from
thee different donors. (B) Lysates of HTNV- or TULV-infected cells (MOI 0.1 or 1) were prepared three
days postinfection. UV-inactivated HTNV was used for mock infection (negative control). Expression
levels of phosphorylated STAT-1 were analysed by Western blot technique using phospho-STAT-1
specific antibodies.
HTNV-infection strongly induced the transcription of the STAT-1 gene three
days postinfection, whereas TULV had only a marginal effect at this time point. In
fact, the observed induction of STAT-1 protein in HTNV-infected cells was more
pronounced compared to a positive control, comprising HUVEC which had been
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stimulated with poly I:C for 24 h prior to the analysis (Figure 29 A). Western blot
analysis of cell lysates obtained from HTNV- or TULV-infected HUVEC verified these
findings (Figure 29 B). An infection of HUVEC with both HTNV or TULV at a low MOI
(0.1) did not result in a distinct upregulation of STAT-1. However, infection at a higher
MOI (1) led to clearly detectable levels of STAT-1 activation in infected HUVEC.
Again, activation of STAT-1 was more pronounced in HTNV-infected HUVEC in
comparison to TULV-infected HUVEC (Figure 29 B).
These findings demonstrate quantitative differences in endothelial cells
concerning transcriptional and activation responses of STAT-1 between pathogenic
HTNV and nonpathogenic TULV.
HTNV and TULV induced MxA protein with different kinetics.
The network of genes stimulated by IFN type I includes MxA, another protein






















































Figure 30. Kinetics of MxA protein expression in HUVEC infected with HTNV or TULV.
Cells were infected with HTNV or TULV (MOI 1) and lysates were prepared at different time points as
indicated. Western blot technique was used to evaluate expression of MxA protein. Lysates of cells
incubated for three days in the absence of virus served as a negative control and lysates of cells
stimulated with poly I:C was used as a positive control. Expression of β-actin was determined to
control the proper loading of SDS-PAGE gels. The results shown are representative of three
independent experiments with cells derived from three different donors.
Thus, induction of MxA protein is an important antiviral parameter which could
determine the outcome of infections with different hantaviruses. Expression levels of
this large GTPase were evaluated by immunoblot in cell lysates of hantavirus-
infected endothelial cells. In comparison to HUVEC treated with poly I:C, which led to
a rapid induction of MxA, HTNV-infected HUVEC showed onset of MxA expression
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only 48 hours postinfection. In contrast, in TULV-infected HUVEC the MxA protein
was already detectable at 16 hours postinfection (Figure 30).
These results indicate that HTNV and TULV induce MxA protein with different
kinetics and could explain the reduced replication rate of TULV in endothelial cells.
3.4.5 Indirect viral effects are for the most part responsible for cellular effects
contributing to hantavirus-induced pathogenesis.
The question arose whether the observed upregulation of HLA class I
molecules on hantavirus-infected HUVEC was caused by the virus itself or rather by
a collateral mediator. In general, soluble factors, for instance, could be secreted by
cells in response to a viral infection and subsequently affect neighbouring cells.
Alternatively, the virus itself, the mere process of infection or viral proteins could
directly provoke a modulation of the protein expression pattern in the infected cell.
To address the question whether hantaviruses primarily affect endothelial cells
by means of triggering cellular IFN-β-secretion or whether a viral protein is directly
triggering the cellular events observed in cell culture, two experimental approaches
were chosen.
Virus-free supernatants of infected HUVEC induced HLA class I upregulation.
After three days of inoculation with HTNV (MOI 1) supernatants of infected
HUVEC were filtrated. Filters were chosen to be tight enough to retain the virus and
porous enough to let pass potentially secreted molecules. Virus-free filtrates were
then used to stimulate untreated HUVEC and HLA class I expression levels were
measured by flow cytometry another three days later. A distinct upregulation of HLA
class I molecules could be detected on HUVEC directly infected with HTNV for three
days (MOI 1) or stimulated with TNFα. As expected, uninfected control HUVEC did
not show increased levels of HLA class I molecules. A stimulation with virus-free
supernatant of infected HUVEC led to slightly augmented expression levels of HLA
class I molecules on the surface of such treated endothelial cells. However, the
upregulation was less pronounced compared to the increase observed on HUVEC
infected with HTNV (Figure 31).
Therefore, upregulation of antigen presentation molecules on the surface of
hantavirus-infected HUVEC could not be solely attributed to viral properties. Some
soluble factor secreted by the virus-infected cell might play a prominent role in
inducing HLA class I-upregulation. IFN, however, are regularly involved in virus-
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unspecific antiviral activity and, in consequence, they were strong candidates to start
with. Moreover, the induction of IFN-β had already been demonstrated in HUVEC
















Figure 31. HLA class I expression after stimulation of HUVEC with filtrated virus-free
supernatants of infected cells.
Cells were infected with HTNV (MOI 1). Supernatants of infected cells were collected three days after
infection and virus was excluded by filtration. Untreated HUVEC were then stimulated with virus-free
supernatants of infected cells for three days. Expression levels of HLA class I molecules were
evaluated by flow cytometry analysis. Untreated HUVEC served as negative control. Direct infection
with HTNV (MOI 1) and treatment with TNFα was used as positive controls. Cells were derived from
three different donors and results are based upon three independent experiments and are given as
mean ± SD.
Anti-IFN-β but not anti-IFN-α antibodies could inhibit HLA class I upregulation
after hantavirus infection.
The contribution of IFN-β to the observed modulation of HLA class I molecules
on HTNV- or TULV-infected HUVEC was investigated. For this purpose, neutralising
anti-IFN-β antibodies or anti-IFN-α antibodies were used. In cultures with HTNV-
infected HUVEC the presence of neutralising anti-IFN-β antibodies reduced
upregulation of HLA class I molecules by 78 % (Figure 32). In contrast, neutralising
anti-IFN-α antibodies had no effect (data not shown). In addition, anti-IFN-β
antibodies were tested for their ability to interfere with TULV-induced HLA class I-
upregulation. Despite the fact that TULV induced comparatively low amounts of IFN-β
the HLA class I enhancement could be efficiently blocked by anti-IFN-β antibodies
(81% inhibition). In contrast, anti-IFN-β antibodies did not prevent upregulation of
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HLA class I molecules on uninfected control cells that had been treated with TNFα
(Figure 32).
HTNV TULV TNF-αIFN-β




















Figure 32. Inhibition of HLA class I-upregulation on HTNV-infected endothelial cells by
anti-IFN-β antibodies.
HUVEC were infected with HTNV (MOI 1) and simultaneously treated with anti-IFN-α or anti-IFN-β
antibodies. Uninfected cells were included as negative control. After three days of infection expression
levels of HLA class I molecules were determined by flow cytometry analysis. Mean fluorescence
intensity (MFI) values are given on the y-axis and are the mean ± SD derived from three individual
experiments. In addition, the % inhibition of HLA class I-enhancement by anti-IFN-β antibodies was
calculated and is shown above the righthand column.
In conclusion, these experiments indicate that IFN-β is for the most part
responsible for the HTNV- and TULV-induced increase of HLA class I molecules on
HUVEC. An important property of the innate immune system is, however, that it
translates its encounter with viruses into an appropriate stimulation of the adaptive
immune system. The limited role of direct effects in hantavirus-associated
pathogenesis suggests that immune-mediated effector mechanisms may be involved.
Indeed, several findings support the idea that hantaviruses can induce a vigorous
cellular immune response. For example, in patients with acute HFRS, greatly
increased numbers of activated CD8-positive T lymphocytes have been detected,
resulting in a reversed CD4-positive/CD8-positive T lymphocyte ratio [Huang, 94].
Moreover, kidney biopsy specimens from patients with PUUV infection are
characterised by infiltrating CD8-positive T lymphocytes [Temonen, 96]. In
accordance with this description, hantavirus infection of endothelial cells has been
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shown to trigger the expression of chemokines that attract T lymphocytes
[Sundstrom, 01]. Activation of antiviral T lymphocytes, particularly in a primary
response, depends critically on the proper function of monocyte-derived dendritic
cells. Moreover, immature dendritic cells which reside in the dermis and epidermis of
the skin and mucosa are among the first immune cells to encounter viruses after their
entry into the human organism [Liu, 01]. These cells are also present in the
epithelium and interstitium of the lungs, the portal of entry for hantaviruses.
Therefore, the ability of pathogenic HTNV to infect human dendritic cells was
investigated.
3.5 Infection of dendritic cells with hantaviruses.
For several reasons, DC represent a major link between the innate and adaptive
immune responses. DC are the most potent antigen-presenting cells (APC) and the
dominant cell type in the activation of naive T lymphocytes.
Immature or mature dendritic cells were infected with pathogenic HTNV at a
very low MOI of 0.1. After four days of infection viral nucleocapsid protein could be
detected in the cytoplasm of infected dendritic cells using immunohistochemistry. Up
to 85 % of the immature and about 50 % of the mature dendritic cells stained positive
at this time point. The punctuated structures and larger twisted threads mirrored the
staining pattern observed in HTNV-infected HUVEC (Figure 33 A). Moreover,
cytopathic effects were not observed in HTNV-infected dendritic cells by microscopic
analysis at any time point during the course of infection.
To confirm productive infection viral titers in the supernatant of HTNV-infected
immature dendritic cells were determined by focus test. The number of infectious
particles released by both immature and mature dendritic cells increased during
infection with HTNV (MOI of 0.05) until a peak was reached around day four
postinfection (Figure 33 B). At later time points virus yields decreased and only low
levels of secreted virus were detected eight days postinfection. Although the kinetic
of infection was similar in both immature and mature dendritic cells, the total number
of infectious particles produced by mature dendritic cells was much lower compared
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Laboratory transmission of hantaviruses from rodents to humans by aerosol
exposure is well documented [Schmaljohn, 99]. Nonrodent-associated laboratory
infections are rare, however, reports from laboratory-acquired infections with HTNV
affirm the potential of a cell culture-adapted HTNV to infect humans [Van Epps, 99;
Shi, 03]. It is therefore of crucial importance to investigate several different
inactivation and clearance techniques and establish procedures for the complete
inactivation or depletion of hantaviruses allowing the use of the treated samples in
subsequent cell biological, virological and immunological assays. It is well
established that enveloped viruses like hantaviruses are readily inactivated, as the
destruction of the lipid membrane is accompanied by a total loss of infectivity.
However, to leave the virus-infected cells almost unchanged and to preserve viral
antigenic properties, heat inactivation or pH-mediated destruction as well as the use
of harsh chemical treatment should be avoided.
4.1.1 Chemical inactivation procedures.
Methanol and acetone act as fat solvents and cause denaturation or
coagulation of proteins. Therefore both solvents are efficient destroyers of enveloped
viruses. In addition, fixation of cells with methanol has the dual effect of
permeabilising them and at the same time allowing the dye to penetrate.
Furthermore, the background fluorescence of the IFA sample is also reduced.
Similarly, paraformaldehyde, like other aldehydes, causes denaturation of nucleic
acids and proteins. Paraformaldehyde maintains cell structure and thereby allows
staining of surface antigens making it a reasonable fixing agent for subsequent IFA
and flow cytometry analyses. In line, it has been demonstrated that methanol,
paraformaldehyde and acetone, used for the fixation of virus-infected cells, efficiently
reduced the number of infectious particles below detection limits, i.e. by at least 6 to
7 log scales.
Recently, inactivation of West Nile virus in a detergent-containing buffer (0.05%   
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Tween 20) has been demonstrated [Mayo, 02]. In our studies performed with
hantaviruses, a complete reduction of viral infectivity (at least 3 log scales) after
lysing infected cells with Nonidet P-40™ containing lysis buffer could be verified. This
procedure allows performance of Western blot analyses outside the biocontainment
facilities.
4.1.2 Viral clearance by physical forces.
Another widely used method for virus inactivation is UV-irradiation [Freitas, 03;
Thurston-Enriquez, 03]. UV-irradiation of HTNV for 3 minutes resulted in a reduction
of infectivity of at least 6 log scales. However, the investigations revealed a clear
dose-dependency for the inactivation kinetics as an incubation time of only one
minute was not sufficient to clear the infectivity completely.
In contrast to the highly efficient virus inactivation by the procedures mentioned
above, filtration using a 1,000 kDa pore size did not clear viral infectivity. A pore size
of 300 kDa, however, reduced the viral infectivity to a level below limits of detection
corresponding to a reduction of at least 5 log scales. This might give also some
indication of the size of viral aggregates. Such filtration experiments suggest particle
dimensions from 300 to 1,000 kDa which is in accordance with the calculated size of
a single virion mass of about 420 kDa [Schmaljohn, 87].
4.1.3 Applicability of inactivated samples in further research assays.
The efficacy of the mentioned inactivation and removal procedures for the
hantavirus type HTNV was verified during the present study. A reduction of infectivity
by different chemical or physical inactivation and virus removal procedures was
clearly demonstrated. In conclusion, different inactivation and depletion procedures
for hantavirus and hantavirus-infected cells have been developed and evaluated. The
efficient clearance of viral infectivity allows the use of HTNV or HTNV-infected cells in
subsequent immunological, cell biological and virological assays. This is evidenced
by the successful use of suchlike treated samples in subsequent
immunofluorescence assays [Sibold, 01], Western blots  (A.A. Kraus, unpubl. data),
cell surface ELISAs (A.A. Kraus, unpubl. data) according to protocols described
previously [Krüll, 96], and flow cytometry analyses [Raftery, 02].
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4.2 The paradox of hantavirus-associated pathogenesis.
Autopsy findings of HFRS and HCPS victims typically reveal the common
feature of increased permeability in microvascular beds, suggesting that the vascular
endothelium may be a primary target for hantavirus infection. Further histological
observations of tissue samples from people with HCPS who died demonstrated that
hantaviruses do not cause detectable cytopathic effects in blood vessel endothelial
cells, despite the presence of hantavirus antigens within these cells [Kanerva, 98;
Zaki, 95]. This development of capillary leakage without visible endothelial damage is
a major paradox of hantavirus pathogenesis. It once again points to the pivotal role
the innate immune response might play in the course of a hantavirus infection.
According to this, hemorrhagic fever viruses could modify hemostatic mechanisms in
two separate ways:
 The first is through direct action on cells involved in hemostasis, such as
platelets and endothelial cells. This would comprise direct effects such as viral host-
shutoff and could manifest itself in altered cell morphology, for instance. Increased
permeability could be triggered through destruction of adherence-type junctions
between endothelial cells or through degradation of the fibrin layer underneath that
supports growth and viability of the endothelium. In fact, as former investigations
have observed, vascular leakage can occur without endothelial cell damage or cell
death [Franke, 87].
The second mechanism depends on the immune system. In the course of
infection, immunopathological events could affect endothelial cells directly by
triggering inflammatory pathways, including activation of transcription factors and
MAP kinases, upregulation of adhesion molecules on the surface of infected cells, as
well as induction of cytokines, namely of IFN. Furthermore, endothelial cells could
also be subject to the destructive action of T lymphocytes after their clonal expansion
due to the presence of infected dendritic cells.
These two pathogenic mechanisms, the direct one without the involvement of
the immune system as well as the immunopathological one, could operate
concurrently, with their relative importance dependent on the manifestations of
disease, the infecting virus, and the person infected.
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4.3 Direct viral effects on HUVEC after infection with hantaviruses.
Although hantaviruses are clearly infectious for endothelial cells, there is little
evidence for direct injury caused by the viral infection. Our findings, that no general
viral host-shutoff was detectable in infected cells correspond to findings of a former
study [Pensiero, 92]. By using RT-PCR and Western blot analyses their work
suggested that different endothelial cell gene products such IL-1, IL-6 or GAPDH
were not affected in steady-state mRNA or protein levels. Similarly, in the present
study levels of β-actin and cyclophilin B were not altered after infection with both
HTNV or TULV as demonstrated in Western blot and RT-PCR analyses. In
accordance with other studies [Hardestam, 03; Pensiero, 92; Zaki, 95], we did not
observe morphological changes in hantavirus-infected endothelial cells. Dendritic
cells could also be productively infected with HTNV in vitro, as demonstrated in the
present study. HTNV did not change cell morphology in both cell types, though, and
did not induce cell death by apoptotic signals mediated by viral replication in
endothelial cells. However, HTNV delivered a strong maturation stimulus to immature
dendritic cells as shown by phenotypic and functional changes and induced the
release of proinflammatory cytokines [Raftery, 02].
Integrins have been identified as cellular receptors for hantaviruses [Mackow,
01]. These molecules, composed of α- and β-subunits, are involved in recognition of
extracellular matrix proteins, cell-cell adhesion and platelet aggregation [Sugimori,
97]. Integrin subunits mediate cellular entry of hantaviruses and their pathogenic
properties may depend on the usage of a particular integrin subtype. In fact, it has
been shown previously, that pathogenic HTNV, SEOV and PUUV use αVβ3 integrins
for cellular entry [Gavrilovskaya, 99]. Since β3 integrins were recently reported to bind
to receptors that regulate vascular permeability [Kevil, 98], it is conceivable that
interactions between hantavirus and β3 integrin may regulate endothelial cell function
and contribute to viral pathogenesis.
Intriguingly, the αvβ3 integrin is one of the receptors involved in antigen uptake
by phagocytes [Albert, 98]. Indeed, histopathological analysis of material from fatal
HCPS cases could already reveal the presence of hantavirus-like particles not only in
endothelial cells but also in dendritic cells, macrophages and lymphocytes [Zaki, 95].
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4.3.1 Failure of hantaviruses to cause cytopathic effects in endothelial cells.
It could be demonstrated in the present study that primary human endothelial
cells are highly susceptible to infection with both HTNV and TULV. However, in vitro
infection with both HTNV or TULV did not lead to any detectable cytopathic effect as
judged by light microscopy. These results are in line with former studies showing the
capability of HTNV to infect Vero cells as well as human endothelial cells without
causing noticeable cytopathic effects [Pensiero, 92]. Pathogenic events occuring
after infection with hantaviruses in humans may therefore not be caused by direct
viral damage to the cells but could be the consequence of immune mediated effects.
Productive infection of human endothelial cells, with or without cytopathology,
has been demonstrated for many DNA and RNA viruses, including Dengue and Junin
virus [Andrews, 78]. Both viruses can cause hemorrhagic fever in humans [Leduc,
89]. However, hemorrhagic fever viruses, including hantaviruses, do not necessarily
cause cytopathic effects.
Generally, viral infection can lead to degenerative changes in infected cells on a
biochemical or morphological basis. Such abnormalities often include shutdown of
cellular RNA and protein synthesis and release of lysosomal enzymes. Visible
morphological changes might comprise viral inclusion bodies, fusion with adjacent
cells to form syncytia and diffuse changes in intracellular structures, and can be
observed easily by light microscopy. Cytopathic effects should not be confused with
necrosis. Necrosis describes the secondary changes that take place after cell death.
Morphological features of a necrotic cell are much different from those of an infected
cell, especially during the early stages of infection.
4.3.2 Apoptosis is not observed in cell culture after infection with
hantaviruses.
Infection with hantaviruses neither changed cell morphology nor induced cell
death in HUVEC or Vero E6 cells by apoptotic signals as judged by TUNEL assay.
Yet another study could not observe effective apoptosis in Vero E6 cells after
infection with HTNV, DOBV or PUUV at any time point either [Hardestam, 03]. In fact,
there is still no clear-cut evidence for induction of apoptosis in infected Vero E6 cells.
Admittedly, in a recent study, HTNV and PHV were shown to induce apoptosis in
Vero E6 cells [Kang, 99]. However, apoptotic events were observed late after
infection and at low levels only, with less than 30 percent of cells showing nuclear
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DNA fragmentation seven days postinfection. And still on day 11 postinfection, about
40% of infected cells remained viable. It looks as if these unpaired findings do not
indicate strong evidence for effective apoptosis in hantavirus-infected Vero E6 cells.
Another study again found that hantaviruses caused cytopathic effects and
induced apoptosis in human embryonic kidney (HEK) cells [Markotic, 03]. It was
observed, though, that apoptosis appeared mostly in uninfected adjacent cells and
rarely in infected HEK cells. It is therefore conceivable that apoptosis occurred rather
independently of hantavirus replication and production of some soluble factors
contributed to apoptosis. The nature of such factor, however, was not identified.
Since control experiments with inactivated hantaviruses were not performed and
infection studies were conducted using varying application rates for different
hantaviruses conclusions drawn from these experiments should be handled with
care. Moreover, a variety of viruses like Herpes simplex virus, parainfluenza virus or
respiratory syncytial virus have been found to cause cytopathic effects in HEK cells
but not in other cell lines [Brown, 86].
Alternatively, hantaviruses might trigger apoptosis in infected cells in the first
instance, but might then be able to counteract cell death. Virally induced expression
of several anti-apoptotic proteins, for example, including cellular inhibitors of
apoptosis (c-IAP) and cellular FLICE inhibitory protein (c-FLIP) could protect
endothelial cells from cell death [Konopleva, 99]. However, induction of these anti-
apoptotic molecules in hantavirus-infected endothelial cells remains to be elucidated
in future studies.
4.4 Inflammatory events after infection with hantaviruses.
Inflammation is a protective response to infection by the immune system that
requires communication between different classes of immune cells to coordinate their
actions. It thereby involves different signalling pathways as well as various cellular
signalling molecules:
The MAPK pathway, for instance, is stimulated by extracellular signals which
initiate an intracellular cascade of phosphorylation events ultimately causing
responses such as growth, differentiation, inflammation and apoptosis. Secreted
cytokines, namely IFN, provide signals between immune cells to coordinate the
inflammatory response. These cytokines, released by activated macrophages, for
example, then trigger endothelial cells to increase expression levels of adhesion
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molecules. Thereby, leukocytes are drawn to the site of inflammation by adherence.
Finally, activation of NFκB is thought to be part of a stress response as it is activated
by a variety of stimuli including growth factors, cytokines, and stress. This results in
the translocation of the molecule to the nucleus, where it activates expression of a
large number of genes that are critical for the regulation of apoptosis, viral replication,
and inflammation, for instance.
4.4.1 Absence of NFκB activation or degradation of IκB-α after hantavirus
infection.
Despite a broad variety of virus-induced pathways leading to the activation of
NFκB, at the level of this central transcription factor and its inhibitor IκB-α cellular
stress responses to infection with both HTNV or TULV could not be observed during
this study. However, these experiments used an in vitro infection model and might
not represent all in vivo events. It is possible that the mentioned proteins are indeed
induced or signalling cascades are activated in human hosts. On the other hand, viral
infection could change the activation state of molecules involved in signalling
cascades. Inactivated phosphatases or inhibition of IκB kinases (IKK) due to viral
manipulation could, for instance, prevent NFκB from disengaging from its inhibitor.
Admittedly, the employed analytical techniques, mainly the IFA, are of limited
sensitivity. Conclusions drawn from IFA are generally qualitative, rather than
quantitative statements. It is therefore conceivable that minor levels of translocation
of NFκB into the nucleus of an infected cell, have been overlooked. Using Western
blot analysis, degradation of IκB to some extent might have been overlooked as well.
Activation of NFκB is a hallmark of most infections including viral infections.
This transcription factor is normally found in the cytoplasm complexed with its
inhibitory protein IκB. Upon infection, signalling events are initiated leading to
phosphorylation of IκB by IKK-α or -β. Phosphorylated IκB is subsequently targeted
for degradation through the ubiquitin-dependent proteasome pathway. Unmasked
NFκB then migrates into the nucleus and activates transcription of NFκB-responsive
genes. These genes encode, for example, a number of cytokines and their receptors,
growth factors, cell adhesion molecules, and many other proteins. These proteins are
involved in various processes, including immune responses, inflammation, cell
growth and differentiation, as well as cell death by apoptosis. Most viruses studied to
date activate NFκB, while a number of different mechanisms seems to be employed
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[Mogensen, 01]. Viral envelope glycoproteins of herpesviruses, for instance, activate
signalling through engagement of cellular receptors. Hepatitis B virus-encoded
proteins, on the other hand, interact with intracellular signalling pathways and
activate NFκB. Generally, accumulation of double-stranded RNA activates PKR,
which in turn stimulates NFκB activity. Alternatively, overload of the endoplasmic
reticulum (ER) due to massive adenovirus protein expression, for instance, can either
lead to activation of NFκB.
4.4.2 MAP kinase signalling pathway is not activated after infection with
HTNV.
During the studies presented here, phosphorylation of MAP kinases ERK and
p38 was not detected in human endothelial cells at any time point postinfection,
neither with HTNV nor with TULV.
These findings do not exclude the possibility that other p38-isoforms (p38-β,
p38-γ or p38-δ) are activated. In fact, hints that these p38 homologes may not be
regulated like p38 itself suggest that they define novel MAP kinase modules
[Robinson, 97]. They might mediate type I IFN effects unrelated to regulation of gene
transcription. Moreover, they might participate in the regulation of IFN-dependent
gene transcription in a cell type-specific manner. Altogether, the precise regulatory
mechanisms by which MAP kinases play a role in type I IFN-dependent transcription
remain to be fully defined.
Finally, other types of endothelial cells, like microvascular endothelial cells
(HMVEC) or lymphatic endothelial cells, might be more applicable endothelial cell
types in the course of human hantavirus infection. It is conceivable that endothelial
cells derived from different sources may react differently to hantavirus infection.
Generally, type I IFN transduce signals by activating the Janus kinase
(JAK)/signal transducer and activator of transcription (STAT) pathway to regulate
transcription of target genes [Darnell, 94]. Additional signalling cascades are
activated by type I IFN receptor, including the p38 MAP kinase pathway [David, 95].
Moreover, several MAP kinases phosphorylate STAT proteins allowing additional
cellular signalling pathways to potentiate the primary STAT-activating stimulus
[Decker, 00].
Among the different MAP kinase subgroups, i.e. ERK, p38 MAP kinases, and
Jun-kinases (JNK), the p38 pathway may play a particular important role in IFN
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signalling [Platanias, 03]. In a recent study, requirement for the p38 pathway in type I
IFN-dependent gene transcription was indeed established. It could be demonstrated
that the function of this MAP kinase cascade is essential for transcription of
essentially all known type I IFN-dependent genes [Li, 04].
4.4.3 Weak upregulation of adhesion molecules after hantavirus infection.
Infection with HTNV or TULV did not lead to significantly increased expression
levels of surface molecules such as ICAM-1, VCAM-1 or E-selectin, as could be
demonstrated by using ELISA technique. Even though slight changes in the density
of ICAM-1 molecules on the surface of infected endothelial cells were observed after
six days of infection by the more sensitive flow cytometry technique, levels of
modulation were altogether weak. A statistically significant increase could therefore
not be determined. In accordance with these findings, a recent study could not detect
significant virus-specific changes in the transcription levels of VCAM-1, ICAM-1, or E-
selectin genes either [Sundstrom, 01]. However, a selective activation of chemokines
RANTES and IP-10 was demonstrated and could provide a mechanism by which
hantavirus infection may direct and perhaps enhance the effector immune response
to the infected microvascular endothelium. It is conceivable that hantavirus infection
of the endothelium may be necessary but insufficient to trigger increases in capillary
leakage associated with HFRS. Both RANTES and IP-10 are predominantly
chemotactic for mononuclear leukocytes, and IP-10 has been shown to be essential
in the development of a protective TH1 response against viral infections in the central
nervous system [Liu, 00]. In contrast to these findings yet another study suggested
that HTNV elicits a unique set of immune cell recruiting and attachment responses
including VCAM, ICAM, and E-Selectin [Geimonen, 02]. These results were,
however, not verified on the protein level but were solely based on the quantification
of cellular mRNA levels.
4.5 Regulation of immunoregulatory proteins in hantavirus-infected HUVEC.
Type I IFN exert potent antiviral activities by inducing genes such as MxA and
dsRNA-activated protein kinase that confer cellular resistance, inhibit viral replication,
and block viral dissemination. They also serve important immunoregulatory roles by
modulating expression of HLA molecules as well as adhesion molecules on the
surface of infected cells.
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4.5.1 Modulated expression levels of antigen presentation molecules.
A drastic increase in the density of HLA class I molecules after infection with
both HTNV or TULV at MOI 1 or higher was observed during our studies. TULV-
infected HUVEC appeared to upregulate HLA class I molecules even more rapidly.
However, induction of HLA class I expression was not observed after infection with
HTNV at MOI of 0.1 despite of the high sensitivity of the cytofluorimetric analysis
compared to ELISA-based methods. Thus, modulation of immunoregulatory proteins
on HUVEC was clearly dose-dependent. This may explain negative data from a
previous study [Sundstrom, 01]. In fact, in that study upregulation of HLA class I
molecules on the surface of hantavirus-infected HMVEC was not observed. This
obvious discrepancy between the observed upregulation of HLA class I molecules on
our hantavirus-infected primary HUVEC and the failure to do so in their primary
HMVEC was dissolved during our kinetic studies using HTNV at considerably
different MOI. This revealed the strong dose-dependent relationship for the observed
HLA modulation. Neither HTNV nor TULV augmented the expression of HLA class II
molecules on HUVEC as revealed by cytofluorimetric analyses.
Expression of HLA class I molecules is essential for the adaptive and innate
antiviral immune response. These molecules serve as recognition elements for T
cells and regulate natural killer (NK) cell function [Natarajan, 02]. Hence, different
viruses decrease antigen processing and presentation which results in down-
regulation of HLA molecules on infected cells, thus helping the viruses to escape the
immune response [Alcami, 00; Tortorella, 00]. Only paramyxoviruses [Garofalo, 96],
flaviviruses [King, 88], and coronaviruses [Suzumura, 86] have so far been reported
to up-regulate the expression of HLA class I-molecules.
A possible mechanism underlying the phenomenon of rapid upregulation of HLA
class I molecules on hantavirus-infected cells is the activation of NFκB. In fact, the
promoter regions of HLA class I-genes contain NFκB binding sites. It has been
reported, for example, that flavivirus-induced HLA class I upregulation is associated
with NFκB translocation into the nucleus [Kesson, 01]. However, using already
established techniques [Krüll, 96] we did not observe any changes in IκB levels and
could not detect NFκB translocation into the nucleus.
In conclusion, hantavirus-induced upregulation of HLA class I-molecules might
depend on mechanisms other than NFκB activation. Alternatively, expression of HLA
class I molecules on the cell surface might be mainly regulated by the transporter
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associated with antigen processing (TAP)-mediated import level of peptides into the
ER rather than by the rate of biosynthesis of HLA class I molecules [Powis, 91].
Enhanced peptide import could then be due to augmented biosynthesis of TAP1 and
TAP2. However, this hypothesis remains to be assessed in future studies.
4.5.2 Production of IFN in infected endothelial cells.
Many viruses enhance expression of HLA class I molecules indirectly through
induction of type I IFN [Samuel, 01; Sen, 01]. In supernatants of HTNV-infected
HUVEC we could detect only moderate levels of IFN-β. In comparison, even less
IFN-β was found in supernatants of TULV-infected cells. Neither HTNV-infected nor
TULV-infected cells released IFN-α. Given the fact that induction of IFN-α/β by
viruses is primarily controlled at the transcriptional level quantitative real-time PCR
was employed for a more detailed analysis. Peak levels of IFN-β mRNA were found
in probes derived from HTNV-infected HUVEC at day 4 postinfection, while levels of
IFN-β mRNA in TULV-infected HUVEC were altogether much lower. No induction of
IFN-α, IFN-γ or IFN-λ was found by employing quantitative real-time RT-PCR.
Similarly, in human endothelial cells from saphenous veins (HSVEC) increased IFN-β
mRNA levels were found at day 3 but not at day 1 after infection with HTNV
[Pensiero, 92]. HTNV-induced IFN-β mRNA production was also observed in yet
another study using DNA array analyses at day 4 postinfection [Geimonen, 02].
However, PHV, a nonpathogenic hantavirus, failed to induce significant IFN-β mRNA
levels in HUVEC in that study [Geimonen, 02]. The comparatively low levels of IFN-β
mRNA in endothelial cells infected with nonpathogenic or rather non pathogenic
hantaviruses could be due to inefficient viral replication and, hence, low production of
double-stranded RNA which triggers synthesis of type I IFN.
One has to keep in mind, though, that related orthobunyaviruses possess an
open reading frame in their S segments encoding for the IFN-antagonistic NSs
protein [Kohl, 03; Weber, 02]. So far, an NSs protein has not been detected in
hantavirus-infected cells. However, hantaviruses associated with rodents from
subfamilies Arvicolinae and Sigmodontinae carry a second open reading frame
(ORF-2) on the S segment, while those associated with Murinae rodents do not have
such an ORF-2 [Plyusnin, 96]. Data from a very recent study suggest that the ORF-2
in both TULV and PUUV is functional and the encoded proteins can indeed
antagonise the IFN response in infected cells [Tulimäki, 04]. This could be an
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alternative explanation for the weak IFN response observed in cells infected with
TULV. However, in the present study a genetic variant of TULV (strain Moravia) was
used which carries a disrupted ORF-2 and does therefore not express a NSs protein
(Rainer Ulrich, personal communication).
Activation of IFN gene expression is a cellular response resulting from innate
immune recognition of virus infection. How cells sense viral replication, though, is
only poorly characterised. While the generation of viral products such as double-
stranded RNA plays a role in the activation of several cellular kinases, additional
signals seem to stimulate phosphorylation of IRF-3 and IRF-7. These are essential
events in induction of a protective IFN response [Smith, 01].
IFN signalling is not impaired in hantavirus-infected endothelial cells.
In our investigations enhanced levels of IFN-β mRNA were mirrored by
increased expression levels of IRF-3 and –7. Moreover, an induction of transcription
factor STAT-1 was observed in hantavirus-infected HUVEC. This is expected since
both IRF-3 and IRF-7 are required to maximally induce the expression of type I IFN.
STAT-1, however, is an important player in the type I IFN-triggered signalling
pathway [Taniguchi, 01].
The virus-induced event that turns on IRF-3 includes activation of a
serine/threonine kinase that phosphorylates IRF-3, allowing the protein to form
dimers. These dimers then translocate to the nucleus and activate transcription. The
kinase responsible for phosphorylation of IRF-3 has not been identified yet, but MAP
kinase p38 has been suggested to be involved in the activation of IRF-3 by
liposaccharide [Navarro, 99]. Activated IRF-3 then stimulates expression of IFN-β.
Resulting IFN-β in turn stimulates production of IRF-7 which remains cytoplasmic in
uninfected cells and becomes activated in virus-infected cells through a mechanism
similar to that used by IRF-3 [Au, 98]. In addition, IRF-3 has been reported to
stimulate Sendai virus-induced RANTES transcription in HEK cells [Lin, 99]. In fact,
IRF-3 was also found to be upregulated in human endothelial cells after infection with
hantaviruses [Sundstrom, 01].
Recent evidence for a type I IFN receptor (IFNAR)-, STAT-1-dependent signal
occurring in the absence of ongoing immune responses to regulate HLA I expression
suggests that a weak constitutive production of type I IFN keeps the host organism in
a state of alertness to incoming virus [Taniguchi, 01]. Future studies will show if the
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IRF-3/IRF-7 system is further involved in virus-induced expression of different
cytokines. The field of virus-induced signalling, which may represent a general
mechanism in host defence to virus infections, has at present been explored only
minimally beyond the model viruses.
Hantavirus infection indirectly affects cellular mechanisms involved in
hantavirus-induced pathogenesis.
The similar kinetics of HTNV-induced IFN-β production and HLA class I-
expression suggested that this cytokine was responsible for the observed HLA class
I-upregulation. By using neutralising antibodies we could show that IFN-β is indeed
crucial for this phenotype. Anti-IFN-β but not anti-IFN-α antibodies could block up to
78 % of the virus-induced effect. Important human pathogens from several other
RNA virus families also induce HLA class I expression through IFN-β on various cell
types: It is known that human parainfluenza virus type 3 and respiratory syncytial
virus increase levels of HLA class I molecules on respiratory epithelial cells via IFN-β
production [Gao, 99; Garofalo, 96]. Similarly, IFN-β mediates induction of HLA class I
expression on a glioma cell line and on HUVEC after infection with measles virus
[Dhib-Jalbut, 93]. Moreover, HLA class I-expression induced by West Nile virus could
be abrogated to a large extent by antibodies directed against type I IFN [Shen, 97].
Unexpectedly, HLA class I-enhancement associated with TULV-infection could
also be prevented (up to 81%) with neutralising anti-IFN-β antibodies although TULV-
infected cells produced only low amounts of IFN-β. It has been demonstrated that a
weak IFN-β signal induced by autocrine/paracrine cytokine secretion is an essential
component in a positive feedback loop [Taniguchi, 01] that could trigger a shortcut in
the activation of the antiviral defense. In fact, induction of IFN-stimulated genes
without enhanced synthesis of type I IFN has been described for virus infected cells
[Navarro, 98] and could involve cellular receptors that recognise viral pathogen-
associated molecular patterns (PAMPs) [Doyle, 02]. Thus, pathogenic hantaviruses
like HTNV might be able to interfere with a weak IFN-β signal thereby disrupting the
positive feed back loop.
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4.6 Differential induction of IFN-dependent proteins and corresponding
immune evasion.
The IFN system is one of the earliest defence mechanisms against virus
infection aquired during evolution. Not surprisingly, millions of years of coevolution
between hosts and their pathogens has resulted in the development of mechanisms
by most viruses to evade, at least to some extent, the host IFN system. There are
several hundred genes transcriptionally regulated by IFN [Der, 98]. Among them,
three families of IFN-inducible genes have been extensively studied with respect to
their antiviral activities. IFN-induced MxA, for instance, confers resistance to infection
by several RNA viruses [Haller, 02]. Although the mechanism of action is not
completely understood, experimental evidence supports a model in which MxA
interferes with cellular trafficking of viral proteins. Generally, it appears that different
viruses antagonise IFN-mediated defence responses by inhibiting distinct steps in
IFN-activated signalling and antiviral pathways.
4.6.1 Different hantaviruses vary in their replication kinetics.
The results presented here demonstrate that human endothelial cells were
highly susceptible to infection with both HTNV or TULV. However, although HUVEC
were clearly capable of supporting growth of HTNV or TULV, production of infectious
virus was limited to early time points after infection. This was then followed by the
establishment of an antiviral state due to induction of IFN-β and MxA. Levels of virus
production declined gradually over the next days and endothelial cells did not
produce significant levels of infectious virus after a week of infection. Vero E6 cells,
on the other hand, continued to produce high levels of virus for the duration of the
experiments of 14 days and probably beyond [Pensiero, 92].
Generally, IFN-induced cytoplasmic MxA interferes with the replication of a
variety of RNA viruses including hantaviruses, Rift valley fever virus or Crimean-
Congo hemorrhagic fever virus [Andersson, 04; Frese, 95]. Vero E6 cells, however,
are devoid of type I IFN genes because of a chromosomal deletion in their genome
[Wathelet, 92]. Hence, they are unable to produce IFN-α/β upon viral infection and,
as a consequence, do not express IFN-regulated genes, including those encoding
endogenous MxA. Accordingly, these cells produce high viral titers after hantavirus
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infection. Thus, endothelial cells can be productively infected with hantaviruses in
vitro and they respond to the infection by activating antiviral signalling pathways.
The limited virus production in human endothelial cells may imply that the
human vascular system is not an active reservoir for infectious virus during the
course of disease. Indeed, recent reports suggested macrophages and dendritic cells
as the target for virus spread in mice and humans [Raftery, 02].
Viral titers produced by TULV-infected human endothelial cells were much
lower than in HTNV-infected endothelial cells, which generated peak titers at 48
hours postinfection. In contrast, on Vero E6 cells which are known to lack type I IFN
genes [Wathelet, 92], TULV could grow as efficiently as HTNV. In fact, exogenously
added human IFN all affect the replication of hantaviruses in Vero E6 cells [Tamura,
87].
Infected endothelial cells, which are not producing infectious virus still contain
significant levels of viral antigen as detected by immunocytochemistry. Two plausible
alternatives could explain this finding. First, hantavirus proteins may have an
extremely long half-life. Secondly, IFN-β-mediated inhibition of hantavirus replication
in endothelial cells occurs at some step in viral replication subsequent to translation
of viral proteins. It has been demonstrated recently that the MxA protein sequesters
the viral N protein thereby trapping this essential virus component in cytoplasmic
inclusions. Hence, the nucleocapsid (N) protein becomes unavailable for the
generation of new virus particles [Kochs, 02].
4.6.2 Early antiviral response is blocked by HTNV but not TULV.
By using Western blot analysis we could detect induction of MxA expression in
HUVEC already 16 h after infection with TULV. This suggests that TULV allows weak
IFN-β signalling which is involved in rapid induction of MxA expression. In this way
TULV replication could be blocked at an early time point resulting in low virus titers.
Accordingly, in Vero E6 cells, which are known to lack type I IFN genes and fail to
mount an antiviral MxA response [Diaz, 88], TULV could grow as efficiently as HTNV.
Supporting this view, in transfected Vero E6 cells expressing MxA replication of
TULV is abrogated [Kanerva, 96a]. In contrast, HTNV delayed the MxA response in
endothelial cells until 48 h postinfection. By this means pathogenic HTNV creates a
time window from 16 h to 48 h postinfection in which it can replicate nearly as
efficiently as in Vero E6 cells. Concomitant with the appearance of MxA the peak titer
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was reached and subsequently declined. Taken together these data suggest that
HTNV but not TULV is able to block the early antiviral immune response in human
endothelial cells.
MxA proteins are IFN-induced GTPases that play a crucial role in the antiviral
response against certain negative-strand RNA viruses [Haller, 98; Weber, 02]:
Orthomyxoviridae [influenza A virus [Pavlovic, 90] and Thogoto virus [Frese, 95]],
Rhabdoviridae [vesicular stomatitis virus [Pavlovic, 90]] and Bunyaviridae [La Crosse
virus, Rift Valley fever virus, sandfly fever virus [Frese, 96], and HTNV [Frese, 96;
Kanerva, 96a]]. It has been shown that MxA interferes with the transport of viral N
protein to the Golgi compartment where assembly of hantaviruses takes place
[Haller, 02]. Through this mechanism the N protein is no longer available for
assembly of new virus particles and viral titers drop.
4.6.3 TULV is targeted by cellular antiviral activity, while HTNV is not – a case
of viral immune evasion.
One of the evasion strategies that have been adopted by large DNA viruses is
to encode homologues of cytokines, chemokines and their receptors, i.e. molecules
that are of crucial importance for the control of the immune response. Human herpes
virus 8, for instance, encodes four IRF homologues, which seem to inhibit cellular
IRF. Alternatively, African swine fever virus blocks the NFκB pathway by gene
products which mimick IκB, the cytoplasmic inhibitor of NFκB. By this means these
viruses appear to block IFN production by directly inhibiting signal transduction
pathways involved in IFN synthesis. It is widely thought, though, that viral double
stranded (ds) RNA intermediates that accumulate during the course of replication are
the primary mediators that trigger IFN production. dsRNA activates cellular kinases,
including PKR, leading to the stimulation of several transcription factors which
participate in promoting IFN expression, such as IRF or NFκB. However, dsRNA is
not present when inactivated virus or a viral attachment protein is used.
Other viruses, including influenza viruses, encode dsRNA-binding proteins in
order to inhibit activation of the dsRNA-induced pathway [Bergmann, 00]. Thus, IFN
production is inhibited as well as the antiviral action of IFN in terms of preventing
activation of dsRNA-induced PKR, which is transcriptionally induced by IFN.
However, viruses such as Ebola virus or Rift valley fever virus with
comparatively small coding capacities had to develop different strategies to avoid the
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host immune system. In fact, mechanisms used by these viruses to inhibit expression
of type I IFN are still unknown [Levy, 01]. Likewise, strategies adopted by HTNV to
evade the antiviral action of type I IFN are also not yet clarified.
The antiviral state is mediated through IFN-regulated cellular proteins such as
MxA, OAS or PKR, which are synthesised after IFN exposure. All IFN-induced genes
share a DNA element present in their 5' promoter regions, called the ISRE [Haque,
98]. To this sequence binds a nuclear factor, designated IFN-stimulated gene factor
(ISGF), which promotes initiation of transcription and acts as enhancer [Ihle, 96]. The
IFN signal transduction pathway is well known [Stark, 98]. Type I IFN receptors are
heterodimers composed of two subunits. Appropriate ligand binding results in
phosphorylation and activation of two tyrosine kinases associated with the subunits of
the receptors, Jak1 and Tyk2. These proteins then phosphorylate STAT-1 and STAT-
2. Phosphorylated STAT-1 and STAT-2 form a complex known as ISGF3 with p48, a
DNA-binding protein. This complex translocates to the cell nucleus where it binds to
ISRE sequences in the promoter region of IFN-stimulated genes, thus activating the
transcriptional machinery. This pathway appears to be a target site for some viruses
to escape host immune survey [Heim, 99; Miller, 99].
Since production of IFN in response to viral infection is one of the main defence
mechanisms of the innate immune system, many viruses have developed strategies
to subvert the IFN system. The S segment of Bunyamwera virus, the prototype of the
Bunyaviridae family, for example, encodes two proteins, the nonstructural NSs
protein and the N protein. While the NSs protein is not essential for viral replication
and transcription, it has been shown that NSs inhibits induction of type I IFN [Weber,
02]. It acts as an IFN induction antagonist that blocks transcriptional activation of type
I IFN in order to increase virulence of Bunyamwera virus. Moreover, as could be
shown recently, Bunyamwera virus NSs protein can delay cell death in the early
stages of infection by inhibiting IRF-3-mediated apoptosis [Kohl, 03]. Similarly, the
NSs protein inherent to members of the Californian serogroup of bunyaviruses has
also been shown to contribute to viral pathogenesis by inhibiting cellular transcription
[Colon-Ramos, 03]. In contrast to other genera of Bunyaviridae, hantaviruses are not
generally known to possess a sequence which would be similar to the ORF for the
IFN-antagonistic NSs protein of related Orthobunyaviruses. In fact, only hantaviruses
carried by Arvicolinae and Sigmodontinae rodents, but not those carried by Murinae
rodents, have an ORF in the S segment. Both hantaviruses used during this study do
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not encode an active NSs protein, though: HTNV like all other hantaviruses carried
by Murinae rodents does not possess an ORF in the S segment. In general TULV,
being associated with Arvicolinae rodents, carry an ORF in their S segment. The
ORF of TULV strain Moravia, which was used during our studies, has a stop codon
within this sequence and, hence, is not functional (Rainer Ulrich, personal
communication).
It is, however, unclear by which means HTNV could interfere with the MxA
response. It has been shown that the inducibility of the MxA protein, a recognised
indicator of IFN action [von Wussow, 90], was inhibited totally in a cell line, which
carried an integrated HBV genome. It was concluded that an HBV gene product
might interact with some component of the IFN signalling pathway or at a pre-
transcriptional level [Fernandez, 03]. Defective HBV genomes reduced antiviral
activity of type I IFN mediated by the HBV core protein and this involved selective
inhibition of the MxA protein but not other IFN-induced genes, such as PKR and
OAS, as shown previously [Rosmorduc, 99]. In fact, these authors have proposed
transcriptional inhibition of MxA promoter activity by the HBV core protein. In the
study presented here, this antiviral protein, which is induced by type I IFN, might also
be inhibited by HTNV. However, an inhibition of type I IFN on the transcriptional or
translational level, without affecting other proteins, did not seem to be the reason,
since a general protein-shutdown in infected cells was not observed. Moreover, it
seemed, that IFN signalling was generally still functioning after an infection with
HTNV, since an induction of IFN response genes, such as IRF-3, IRF-7, OAS or
STAT was still observed by using RT-PCR and Western blot analyses. It is therefore
conceivable that interference of HTNV with the MxA response occurred far
downstream on the level of signalling, possibly by directly disrupting the MxA
production.
TULV, on the other hand, only inefficiently induced the expression of IFN-β,
probably due to a low replication rate. It was therefore a target of the antiviral activity
of IFN-induced MxA protein. The comparatively high levels of HTNV, which imply
high levels of viral protein production, point to a possible interaction of some viral
proteins with the transcription machinery of the type I IFN system.
Of the innate immune response, type I IFN-induced factors appear to exert the
most pronounced antiviral effect in hantavirus infection. The essential role of type I
IFN in the host to combat infection is highlighted by the uncontrolled virus growth in
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Vero E6 cells which are deficient in type I IFN genes. Moreover, type I IFN receptor
knockout mice are even more susceptible to HTNV infections [Wichmann, 02]. There
is evidence to suggest, however, that HTNV is very well able to interfere with IFN-
induced host factors, namely with the MxA protein. This antivirally active protein was
at least not induced by HTNV until two days of infection. In fact, strategies which
confer resistance to type I IFN-induced host factors have been described for
numerous other viruses, including hepatitis C virus and Vaccinia virus [Katze, 02].
4.7 Human hantavirus infection and the involvement of immune cells -
Concept of immunopathogenesis.
HLA class I molecules, which serve as target structures for antiviral T cells,
could be relevant to the hantavirus-associated pathogenesis as severity of the clinical
course in humans may correlate with HLA type [Makela, 02; Mustonen, 96].
We could demonstrate for the first time that hantaviruses infect DC, which
represent the most potent professional antigen-presenting cells (APC) of the host
immune system. In an exhaustive study by Raftery et al. (2002) it could be
demonstrated that hantaviruses, unlike HIV [Macatonia, 92], measles virus [Fugier-
Vivier, 97; Grosjean, 97], or HCMV [Raftery, 01], induce upregulation of
immunologically relevant molecules on DC. Expression of HLA class I and II
molecules as well as the density of co-stimulatory molecules was increased
representing a more mature phenotype. These phenotypic changes should be
mirrored by functional changes. In fact, hantavirus-infected DC were able to stimulate
T lymphocytes more efficiently, indicating an enhanced antigen presenting capacity
of these important APC [Raftery, 02]. These findings imply that hantaviruses can
elicit a strong T lymphocyte response which could significantly contribute to
hantavirus-associated immunopathology.
Furthermore, it is conceivable that a delayed MxA response could allow
pathogenic HTNV to spread more efficiently in the endothelial cell layer and
upregulate HLA class I molecules on a higher proportion of cells (Figure 34).
Accordingly, antiviral CD8-positive T lymphocytes may cause more extensive
damage during elimination of cells infected with HTNV. Such effects could also be
demonstrated for noncytolytic lymphocytic choriomeningitis virus (LCMV), for
instance, as experiments with knockout mice could clearly show that tissue damage
during infection requires CD8-positive T lymphocytes [Fung-Leung, 91]. In addition,
increased IFN-β release by endothelial cells infected with pathogenic HTNV could
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aggravate inflammatory processes that possibly contribute to endothelial dysfunction.
Although precise functional consequences of these differences between pathogenic
HTNV and rather nonpathogenic TULV remain to be elucidated in vivo they are most
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Figure 34. Differential antiviral response of endothelial cells.
Fast onset of the innate immune response, in particular an early induction of antivirally active MxA
protein, limits viral spread. Therefore, only marginal damage is caused by TULV infection due to the
comparatively low number of infected endothelial cells. In contrast, the MxA reponse is delayed after
HTNV infection, which enables the virus to spread more efficiently in the endothelial cell layer.
Consequently, extensive damage might be observed in the endothelial barrier since effector T
lymphocytes have to destroy a relatively high number of endothelial cells to clear the viral infection.
Natural killer (NK) cell proliferation is induced by type I IFN, and the antiviral
function of NK cells is thought to be important mainly in the first few days
postinfection [Biron, 99]. It has been shown that flavivirus-infected target cells are
significantly protected from lysis by ex vivo NK cells relative to uninfected targets
[Lobigs, 03]. This might be a consquence of virus-mediated HLA class I upregulation
[Lobigs, 96]. In case that kinetics of viremia coincides with that of the peak NK cell
response observed in most viral infections in vivo, the viral effect on HLA class I
expression might have physiological relevance in counteracting host NK cell defence.
However, this hypothesis remains to be elucidated in detail for hantavirus infections.
In some viral hemorrhagic fevers, such as HFRS or Dengue hemorrhagic fever
(DHF) as well as dengue shock syndrome (DSS), manifestations of disease appear
to be clearly related to a powerful and destructive immune response [Lei, 01]. In
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others, such as in Ebola virus infections, these manifestations seem to reflect
compromised immunity with inability to check viremia and its consequences [Fisher-
Hoch, 92]. In both cases, changes in cytokine elaboration could play a prominent

















Figure 35. Hantaviruses and a concept of immunopathogenesis.
Immature dendritic cells in the lung are among the first cells to be infected by the virus. Hantavirus
infection represents a strong maturation stimulus and infected dendritic cells aquire full T lymphocyte
stimulatory capacity. Eventually, effector T lymphocytes reach the endothelium and eliminate
endothelial cells expressing hantaviral antigens on their surface.
Endothelial cells and monocytes are thought to be the primary cell types
infected by the virus, but infection has no direct cytopathic effect on these cells
[Pensiero, 92; Temonen, 93; Zaki, 95]. Several studies have suggested that the
clinical syndromes caused by hantavirus infection may be mediated in part by
immunopathologic mechanisms, including the action of virus-specific CD8-positive
and CD4-positive T lymphocytes [Van Epps, 99; Van Epps, 02]. Evidence to suggest
this includes increases in the numbers of activated circulating CD8-positive T
lymphocytes that are seen during HFRS and in kidney biopsies from patients with
acute PUUV infections [Temonen, 96].
In airways and alveoli, in fact, a network of immature DC is located in the
vicinity of epithelial cells and  these important immune cells take up pathogens which
are inhaled by humans. It has been shown that hantaviruses can productively infect
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DC in vitro without causing significant cell death [Raftery, 02]. Infection of DC may
facilitate transmission and dissemination of the virus throughout the body. In general,
virus-infected DC are functionally impaired. However, DC infected with hantaviruses
behave differently and acquire full T lymphocyte-stimulatory capacity in vitro.
Therefore, it can be assumed that hantavirus-infected DC could efficiently stimulate a
strong adaptive immune response against viral antigens in secondary lymphoid
organs. Effector T lymphocytes resulting thereof could reach the infected organs via
the bloodstream and eliminate endothelial cells expressing hantaviral antigens. In
case of TULV this may cause only marginal damage because a fast onset of the
innate immune response, i.e. expression of antiviral MxA protein, limits the number of
infected endothelial cells. In contrast, we found that pathogenic HTNV delays the
MxA-reponse allowing more efficient spread in the endothelial cell layer in vitro
[Kraus, 04]. As a consequence effector T lymphocytes might have to destroy a
relatively high number of endothelial cells to clear the viral infection thereby
damaging the endothelial barrier and causing symptoms. In conclusion, peculiar
interactions of hantaviruses with the host immune system might determine their
pathogenicity.
The precise functional consequences of the differences between pathogenic
and rather nonpathogenic hantaviruses remain to be elucidated in vivo. They are
most likely of pivotal importance for the pathogenesis of hantavirus-associated
diseases. Accordingly, it will be of great interest to see whether DC isolated from the
animal hosts can also be infected by hantaviruses. To further test the in vivo
relevance of hantavirus infection of DC the recently described syrian hamster model
may provide a suitable means [Hooper, 01].
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Appendix















8 min lysate 1.5×10





7 > 50 > 3×105
paraformaldehyde (1%)
20 min lysate 1×10





6 > 50 > 2×104
acetone/methanol (1 :1)
10 min lysate 4×10




lysate 5×103 > 50 > 1×102
UV-irradiation
1 min virus solution 1.7×10
6 2×102 8.5×103
UV-irradiation
3 min virus solution 1.7×10
6 > 10 >1.7×105
filtration
300 kDa filtrate 1.5×10
5 > 10 > 1.5×104
filtration
1,000 kDa filtrate 1.5×10
5 1×105 1.5
